Reunió 20/10/2020
Lípid de referencia: PI 34:1
Resultats PI 34:1 Sa Low vs Tumor High
Cluster Sample
Determinació Beta
Cluster gens
Correlació mòduls i fenotips
Gens drivers dels mòduls associats al fenotip
GO
Es mostren els 10 millors GO
| X | module | size | p.val | Bonf | nInTerm | GO.id | ont | term.name |
|---|---|---|---|---|---|---|---|---|
| 1 | antiquewhite4 | 39 | 4.0e-05 | 0.740 | 2 | GO:0099012 | CC | neuronal dense core vesicle membrane |
| 2 | antiquewhite4 | 39 | 1.0e-04 | 1.000 | 2 | GO:0032127 | CC | dense core granule membrane |
| 3 | antiquewhite4 | 39 | 1.4e-04 | 1.000 | 2 | GO:1990504 | BP | dense core granule exocytosis |
| 4 | antiquewhite4 | 39 | 3.0e-04 | 1.000 | 2 | GO:0098992 | CC | neuronal dense core vesicle |
| 5 | antiquewhite4 | 39 | 1.6e-03 | 1.000 | 2 | GO:0031045 | CC | dense core granule |
| 6 | antiquewhite4 | 39 | 2.6e-03 | 1.000 | 1 | GO:0010164 | BP | response to cesium ion |
| 7 | antiquewhite4 | 39 | 2.6e-03 | 1.000 | 1 | GO:0043128 | BP | positive regulation of 1-phosphatidylinositol 4-kinase activity |
| 8 | antiquewhite4 | 39 | 2.6e-03 | 1.000 | 1 | GO:0048174 | BP | negative regulation of short-term neuronal synaptic plasticity |
| 9 | antiquewhite4 | 39 | 2.6e-03 | 1.000 | 1 | GO:0061782 | BP | vesicle fusion with vesicle |
| 10 | antiquewhite4 | 39 | 2.6e-03 | 1.000 | 1 | GO:0099161 | BP | regulation of presynaptic dense core granule exocytosis |
| 11 | bisque4 | 64 | 7.8e-04 | 1.000 | 3 | GO:0007080 | BP | mitotic metaphase plate congression |
| 12 | bisque4 | 64 | 1.0e-03 | 1.000 | 3 | GO:0032210 | BP | regulation of telomere maintenance via telomerase |
| 13 | bisque4 | 64 | 1.1e-03 | 1.000 | 3 | GO:0007585 | BP | respiratory gaseous exchange by respiratory system |
| 14 | bisque4 | 64 | 1.4e-03 | 1.000 | 3 | GO:1904356 | BP | regulation of telomere maintenance via telomere lengthening |
| 15 | bisque4 | 64 | 1.7e-03 | 1.000 | 3 | GO:0007004 | BP | telomere maintenance via telomerase |
| 16 | bisque4 | 64 | 1.8e-03 | 1.000 | 3 | GO:0006278 | BP | RNA-dependent DNA biosynthetic process |
| 17 | bisque4 | 64 | 1.8e-03 | 1.000 | 3 | GO:0051310 | BP | metaphase plate congression |
| 18 | bisque4 | 64 | 2.0e-03 | 1.000 | 2 | GO:1904355 | BP | positive regulation of telomere capping |
| 19 | bisque4 | 64 | 2.7e-03 | 1.000 | 3 | GO:0010833 | BP | telomere maintenance via telomere lengthening |
| 20 | bisque4 | 64 | 2.7e-03 | 1.000 | 3 | GO:0070098 | BP | chemokine-mediated signaling pathway |
| 21 | black | 311 | 1.7e-04 | 1.000 | 3 | GO:0051344 | BP | negative regulation of cyclic-nucleotide phosphodiesterase activity |
| 22 | black | 311 | 1.2e-03 | 1.000 | 4 | GO:0042573 | BP | retinoic acid metabolic process |
| 23 | black | 311 | 1.3e-03 | 1.000 | 3 | GO:0043023 | MF | ribosomal large subunit binding |
| 24 | black | 311 | 1.4e-03 | 1.000 | 19 | GO:0010817 | BP | regulation of hormone levels |
| 25 | black | 311 | 1.7e-03 | 1.000 | 3 | GO:0034755 | BP | iron ion transmembrane transport |
| 26 | black | 311 | 2.2e-03 | 1.000 | 4 | GO:0097386 | CC | glial cell projection |
| 27 | black | 311 | 2.5e-03 | 1.000 | 2 | GO:0015990 | BP | electron transport coupled proton transport |
| 28 | black | 311 | 2.5e-03 | 1.000 | 2 | GO:0030274 | MF | LIM domain binding |
| 29 | black | 311 | 2.5e-03 | 1.000 | 2 | GO:1990757 | MF | ubiquitin ligase activator activity |
| 30 | black | 311 | 2.7e-03 | 1.000 | 3 | GO:0032048 | BP | cardiolipin metabolic process |
| 31 | blue | 2536 | 1.8e-04 | 1.000 | 46 | GO:0030658 | CC | transport vesicle membrane |
| 32 | blue | 2536 | 2.4e-04 | 1.000 | 142 | GO:0012506 | CC | vesicle membrane |
| 33 | blue | 2536 | 3.0e-04 | 1.000 | 63 | GO:0030667 | CC | secretory granule membrane |
| 34 | blue | 2536 | 5.7e-04 | 1.000 | 136 | GO:0030659 | CC | cytoplasmic vesicle membrane |
| 35 | blue | 2536 | 7.1e-04 | 1.000 | 59 | GO:0030135 | CC | coated vesicle |
| 36 | blue | 2536 | 9.6e-04 | 1.000 | 15 | GO:0032570 | BP | response to progesterone |
| 37 | blue | 2536 | 1.3e-03 | 1.000 | 7 | GO:0007158 | BP | neuron cell-cell adhesion |
| 38 | blue | 2536 | 1.4e-03 | 1.000 | 68 | GO:0016050 | BP | vesicle organization |
| 39 | blue | 2536 | 1.9e-03 | 1.000 | 9 | GO:0002080 | CC | acrosomal membrane |
| 40 | blue | 2536 | 2.0e-03 | 1.000 | 5 | GO:0001842 | BP | neural fold formation |
| 41 | blue2 | 30 | 4.0e-04 | 1.000 | 5 | GO:0018205 | BP | peptidyl-lysine modification |
| 42 | blue2 | 30 | 1.6e-03 | 1.000 | 3 | GO:0005814 | CC | centriole |
| 43 | blue2 | 30 | 1.9e-03 | 1.000 | 1 | GO:0070054 | BP | mRNA splicing, via endonucleolytic cleavage and ligation |
| 44 | blue2 | 30 | 1.9e-03 | 1.000 | 1 | GO:1990579 | BP | peptidyl-serine trans-autophosphorylation |
| 45 | blue2 | 30 | 1.9e-03 | 1.000 | 1 | GO:1990332 | CC | Ire1 complex |
| 46 | blue2 | 30 | 1.9e-03 | 1.000 | 1 | GO:1990630 | CC | IRE1-RACK1-PP2A complex |
| 47 | blue2 | 30 | 1.9e-03 | 1.000 | 1 | GO:0004043 | MF | L-aminoadipate-semialdehyde dehydrogenase activity |
| 48 | blue2 | 30 | 1.9e-03 | 1.000 | 1 | GO:0008802 | MF | betaine-aldehyde dehydrogenase activity |
| 49 | blue2 | 30 | 1.9e-03 | 1.000 | 1 | GO:0018025 | MF | calmodulin-lysine N-methyltransferase activity |
| 50 | blue2 | 30 | 2.3e-03 | 1.000 | 3 | GO:0016573 | BP | histone acetylation |
| 51 | brown | 2061 | 1.0e-04 | 1.000 | 37 | GO:0030832 | BP | regulation of actin filament length |
| 52 | brown | 2061 | 1.3e-04 | 1.000 | 41 | GO:0008154 | BP | actin polymerization or depolymerization |
| 53 | brown | 2061 | 1.7e-04 | 1.000 | 80 | GO:0015629 | CC | actin cytoskeleton |
| 54 | brown | 2061 | 1.8e-04 | 1.000 | 49 | GO:0110053 | BP | regulation of actin filament organization |
| 55 | brown | 2061 | 2.0e-04 | 1.000 | 36 | GO:0008064 | BP | regulation of actin polymerization or depolymerization |
| 56 | brown | 2061 | 2.5e-04 | 1.000 | 5 | GO:0006616 | BP | SRP-dependent cotranslational protein targeting to membrane, translocation |
| 57 | brown | 2061 | 2.8e-04 | 1.000 | 138 | GO:0099512 | CC | supramolecular fiber |
| 58 | brown | 2061 | 3.3e-04 | 1.000 | 71 | GO:0007015 | BP | actin filament organization |
| 59 | brown | 2061 | 4.0e-04 | 1.000 | 9 | GO:0046039 | BP | GTP metabolic process |
| 60 | brown | 2061 | 5.0e-04 | 1.000 | 59 | GO:0032956 | BP | regulation of actin cytoskeleton organization |
| 61 | brown2 | 34 | 1.5e-05 | 0.280 | 2 | GO:0035877 | MF | death effector domain binding |
| 62 | brown2 | 34 | 5.0e-05 | 0.920 | 2 | GO:0097342 | CC | ripoptosome |
| 63 | brown2 | 34 | 7.5e-05 | 1.000 | 2 | GO:0031265 | CC | CD95 death-inducing signaling complex |
| 64 | brown2 | 34 | 1.1e-04 | 1.000 | 2 | GO:0097200 | MF | cysteine-type endopeptidase activity involved in execution phase of apoptosis |
| 65 | brown2 | 34 | 1.4e-04 | 1.000 | 2 | GO:0097199 | MF | cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
| 66 | brown2 | 34 | 1.8e-04 | 1.000 | 2 | GO:0031264 | CC | death-inducing signaling complex |
| 67 | brown2 | 34 | 3.3e-04 | 1.000 | 2 | GO:0097153 | MF | cysteine-type endopeptidase activity involved in apoptotic process |
| 68 | brown2 | 34 | 1.4e-03 | 1.000 | 2 | GO:0035666 | BP | TRIF-dependent toll-like receptor signaling pathway |
| 69 | brown2 | 34 | 1.8e-03 | 1.000 | 2 | GO:0002756 | BP | MyD88-independent toll-like receptor signaling pathway |
| 70 | brown2 | 34 | 2.3e-03 | 1.000 | 1 | GO:0003311 | BP | pancreatic D cell differentiation |
| 71 | brown4 | 63 | 3.0e-03 | 1.000 | 2 | GO:0001556 | BP | oocyte maturation |
| 72 | brown4 | 63 | 4.0e-03 | 1.000 | 2 | GO:0017025 | MF | TBP-class protein binding |
| 73 | brown4 | 63 | 4.3e-03 | 1.000 | 1 | GO:0002215 | BP | defense response to nematode |
| 74 | brown4 | 63 | 4.3e-03 | 1.000 | 1 | GO:0010121 | BP | arginine catabolic process to proline via ornithine |
| 75 | brown4 | 63 | 4.3e-03 | 1.000 | 1 | GO:0019544 | BP | arginine catabolic process to glutamate |
| 76 | brown4 | 63 | 4.3e-03 | 1.000 | 1 | GO:0035713 | BP | response to nitrogen dioxide |
| 77 | brown4 | 63 | 4.3e-03 | 1.000 | 1 | GO:0071954 | BP | chemokine (C-C motif) ligand 11 production |
| 78 | brown4 | 63 | 4.3e-03 | 1.000 | 1 | GO:1900281 | BP | positive regulation of CD4-positive, alpha-beta T cell costimulation |
| 79 | brown4 | 63 | 4.3e-03 | 1.000 | 1 | GO:2000572 | BP | positive regulation of interleukin-4-dependent isotype switching to IgE isotypes |
| 80 | brown4 | 63 | 4.3e-03 | 1.000 | 1 | GO:0016028 | CC | rhabdomere |
| 81 | coral1 | 40 | 1.0e-04 | 1.000 | 2 | GO:0070309 | BP | lens fiber cell morphogenesis |
| 82 | coral1 | 40 | 3.7e-04 | 1.000 | 2 | GO:0070307 | BP | lens fiber cell development |
| 83 | coral1 | 40 | 1.1e-03 | 1.000 | 2 | GO:2000678 | BP | negative regulation of transcription regulatory region DNA binding |
| 84 | coral1 | 40 | 1.2e-03 | 1.000 | 2 | GO:0002089 | BP | lens morphogenesis in camera-type eye |
| 85 | coral1 | 40 | 1.8e-03 | 1.000 | 2 | GO:0019048 | BP | modulation by virus of host process |
| 86 | coral1 | 40 | 2.4e-03 | 1.000 | 2 | GO:0070306 | BP | lens fiber cell differentiation |
| 87 | coral1 | 40 | 2.5e-03 | 1.000 | 3 | GO:1904375 | BP | regulation of protein localization to cell periphery |
| 88 | coral1 | 40 | 2.6e-03 | 1.000 | 1 | GO:0003165 | BP | Purkinje myocyte development |
| 89 | coral1 | 40 | 2.6e-03 | 1.000 | 1 | GO:0016203 | BP | muscle attachment |
| 90 | coral1 | 40 | 2.6e-03 | 1.000 | 1 | GO:0021682 | BP | nerve maturation |
| 91 | coral2 | 38 | 5.9e-04 | 1.000 | 2 | GO:0050765 | BP | negative regulation of phagocytosis |
| 92 | coral2 | 38 | 7.6e-04 | 1.000 | 2 | GO:0045954 | BP | positive regulation of natural killer cell mediated cytotoxicity |
| 93 | coral2 | 38 | 1.1e-03 | 1.000 | 2 | GO:0002717 | BP | positive regulation of natural killer cell mediated immunity |
| 94 | coral2 | 38 | 1.8e-03 | 1.000 | 5 | GO:0034765 | BP | regulation of ion transmembrane transport |
| 95 | coral2 | 38 | 2.4e-03 | 1.000 | 1 | GO:0050652 | BP | dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process |
| 96 | coral2 | 38 | 2.4e-03 | 1.000 | 1 | GO:0060819 | BP | inactivation of X chromosome by genetic imprinting |
| 97 | coral2 | 38 | 2.4e-03 | 1.000 | 1 | GO:1900383 | BP | regulation of synaptic plasticity by receptor localization to synapse |
| 98 | coral2 | 38 | 2.4e-03 | 1.000 | 1 | GO:2000808 | BP | negative regulation of synaptic vesicle clustering |
| 99 | coral2 | 38 | 2.4e-03 | 1.000 | 1 | GO:0051800 | MF | phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity |
| 100 | coral2 | 38 | 2.7e-03 | 1.000 | 2 | GO:0042269 | BP | regulation of natural killer cell mediated cytotoxicity |
| 101 | cyan | 169 | 7.6e-05 | 1.000 | 16 | GO:0010608 | BP | posttranscriptional regulation of gene expression |
| 102 | cyan | 169 | 1.2e-04 | 1.000 | 2 | GO:0090065 | BP | regulation of production of siRNA involved in RNA interference |
| 103 | cyan | 169 | 1.2e-04 | 1.000 | 2 | GO:0098759 | BP | cellular response to interleukin-8 |
| 104 | cyan | 169 | 1.9e-04 | 1.000 | 18 | GO:0043604 | BP | amide biosynthetic process |
| 105 | cyan | 169 | 3.7e-04 | 1.000 | 2 | GO:0005030 | MF | neurotrophin receptor activity |
| 106 | cyan | 169 | 3.9e-04 | 1.000 | 21 | GO:0004888 | MF | transmembrane signaling receptor activity |
| 107 | cyan | 169 | 4.6e-04 | 1.000 | 11 | GO:0006417 | BP | regulation of translation |
| 108 | cyan | 169 | 5.9e-04 | 1.000 | 4 | GO:0001754 | BP | eye photoreceptor cell differentiation |
| 109 | cyan | 169 | 7.3e-04 | 1.000 | 2 | GO:2000623 | BP | negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay |
| 110 | cyan | 169 | 8.1e-04 | 1.000 | 11 | GO:0043235 | CC | receptor complex |
| 111 | darkgreen | 125 | 4.8e-05 | 0.870 | 3 | GO:2000574 | BP | regulation of microtubule motor activity |
| 112 | darkgreen | 125 | 5.7e-05 | 1.000 | 8 | GO:0099111 | BP | microtubule-based transport |
| 113 | darkgreen | 125 | 1.4e-04 | 1.000 | 10 | GO:0007018 | BP | microtubule-based movement |
| 114 | darkgreen | 125 | 3.2e-04 | 1.000 | 6 | GO:0016298 | MF | lipase activity |
| 115 | darkgreen | 125 | 3.3e-04 | 1.000 | 14 | GO:0097435 | BP | supramolecular fiber organization |
| 116 | darkgreen | 125 | 5.1e-04 | 1.000 | 4 | GO:0009395 | BP | phospholipid catabolic process |
| 117 | darkgreen | 125 | 5.5e-04 | 1.000 | 4 | GO:0061178 | BP | regulation of insulin secretion involved in cellular response to glucose stimulus |
| 118 | darkgreen | 125 | 6.2e-04 | 1.000 | 43 | GO:0006996 | BP | organelle organization |
| 119 | darkgreen | 125 | 6.4e-04 | 1.000 | 6 | GO:0046434 | BP | organophosphate catabolic process |
| 120 | darkgreen | 125 | 7.3e-04 | 1.000 | 16 | GO:0099512 | CC | supramolecular fiber |
| 121 | darkgrey | 119 | 6.3e-05 | 1.000 | 2 | GO:0070966 | BP | nuclear-transcribed mRNA catabolic process, no-go decay |
| 122 | darkgrey | 119 | 6.2e-04 | 1.000 | 2 | GO:0098937 | BP | anterograde dendritic transport |
| 123 | darkgrey | 119 | 2.3e-03 | 1.000 | 3 | GO:0030118 | CC | clathrin coat |
| 124 | darkgrey | 119 | 2.3e-03 | 1.000 | 3 | GO:0030119 | CC | AP-type membrane coat adaptor complex |
| 125 | darkgrey | 119 | 2.7e-03 | 1.000 | 2 | GO:0019896 | BP | axonal transport of mitochondrion |
| 126 | darkgrey | 119 | 3.3e-03 | 1.000 | 2 | GO:0008298 | BP | intracellular mRNA localization |
| 127 | darkgrey | 119 | 4.5e-03 | 1.000 | 3 | GO:0007019 | BP | microtubule depolymerization |
| 128 | darkgrey | 119 | 4.5e-03 | 1.000 | 3 | GO:0008089 | BP | anterograde axonal transport |
| 129 | darkgrey | 119 | 4.6e-03 | 1.000 | 2 | GO:0030014 | CC | CCR4-NOT complex |
| 130 | darkgrey | 119 | 6.9e-03 | 1.000 | 3 | GO:1904115 | CC | axon cytoplasm |
| 131 | darkmagenta | 81 | 4.5e-04 | 1.000 | 2 | GO:2000020 | BP | positive regulation of male gonad development |
| 132 | darkmagenta | 81 | 9.1e-04 | 1.000 | 4 | GO:0005604 | CC | basement membrane |
| 133 | darkmagenta | 81 | 1.1e-03 | 1.000 | 2 | GO:0032700 | BP | negative regulation of interleukin-17 production |
| 134 | darkmagenta | 81 | 1.1e-03 | 1.000 | 2 | GO:0060221 | BP | retinal rod cell differentiation |
| 135 | darkmagenta | 81 | 1.3e-03 | 1.000 | 2 | GO:1900272 | BP | negative regulation of long-term synaptic potentiation |
| 136 | darkmagenta | 81 | 1.8e-03 | 1.000 | 3 | GO:0031648 | BP | protein destabilization |
| 137 | darkmagenta | 81 | 2.0e-03 | 1.000 | 3 | GO:0043525 | BP | positive regulation of neuron apoptotic process |
| 138 | darkmagenta | 81 | 3.1e-03 | 1.000 | 4 | GO:0007292 | BP | female gamete generation |
| 139 | darkmagenta | 81 | 3.1e-03 | 1.000 | 4 | GO:0019083 | BP | viral transcription |
| 140 | darkmagenta | 81 | 3.4e-03 | 1.000 | 5 | GO:0045137 | BP | development of primary sexual characteristics |
| 141 | darkolivegreen | 92 | 3.8e-04 | 1.000 | 2 | GO:0009374 | MF | biotin binding |
| 142 | darkolivegreen | 92 | 6.1e-04 | 1.000 | 3 | GO:0010575 | BP | positive regulation of vascular endothelial growth factor production |
| 143 | darkolivegreen | 92 | 6.7e-04 | 1.000 | 4 | GO:0003777 | MF | microtubule motor activity |
| 144 | darkolivegreen | 92 | 6.9e-04 | 1.000 | 5 | GO:0007259 | BP | receptor signaling pathway via JAK-STAT |
| 145 | darkolivegreen | 92 | 8.4e-04 | 1.000 | 3 | GO:0010574 | BP | regulation of vascular endothelial growth factor production |
| 146 | darkolivegreen | 92 | 8.4e-04 | 1.000 | 5 | GO:0097696 | BP | receptor signaling pathway via STAT |
| 147 | darkolivegreen | 92 | 1.1e-03 | 1.000 | 3 | GO:0010573 | BP | vascular endothelial growth factor production |
| 148 | darkolivegreen | 92 | 1.3e-03 | 1.000 | 2 | GO:0006768 | BP | biotin metabolic process |
| 149 | darkolivegreen | 92 | 2.0e-03 | 1.000 | 2 | GO:0042574 | BP | retinal metabolic process |
| 150 | darkolivegreen | 92 | 2.4e-03 | 1.000 | 3 | GO:0090382 | BP | phagosome maturation |
| 151 | darkolivegreen4 | 31 | 2.1e-03 | 1.000 | 1 | GO:0010045 | BP | response to nickel cation |
| 152 | darkolivegreen4 | 31 | 2.1e-03 | 1.000 | 1 | GO:0005914 | CC | spot adherens junction |
| 153 | darkolivegreen4 | 31 | 2.1e-03 | 1.000 | 1 | GO:0047936 | MF | glucose 1-dehydrogenase [NAD(P)] activity |
| 154 | darkolivegreen4 | 31 | 2.7e-03 | 1.000 | 2 | GO:0007431 | BP | salivary gland development |
| 155 | darkolivegreen4 | 31 | 4.3e-03 | 1.000 | 1 | GO:0010983 | BP | positive regulation of high-density lipoprotein particle clearance |
| 156 | darkolivegreen4 | 31 | 4.3e-03 | 1.000 | 1 | GO:0090675 | BP | intermicrovillar adhesion |
| 157 | darkolivegreen4 | 31 | 4.3e-03 | 1.000 | 1 | GO:0004345 | MF | glucose-6-phosphate dehydrogenase activity |
| 158 | darkolivegreen4 | 31 | 4.3e-03 | 1.000 | 1 | GO:0017057 | MF | 6-phosphogluconolactonase activity |
| 159 | darkolivegreen4 | 31 | 4.3e-03 | 1.000 | 1 | GO:0086059 | MF | voltage-gated calcium channel activity involved SA node cell action potential |
| 160 | darkolivegreen4 | 31 | 4.5e-03 | 1.000 | 2 | GO:0035272 | BP | exocrine system development |
| 161 | darkorange | 108 | 1.4e-06 | 0.026 | 10 | GO:2000116 | BP | regulation of cysteine-type endopeptidase activity |
| 162 | darkorange | 108 | 4.2e-06 | 0.077 | 9 | GO:0043281 | BP | regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| 163 | darkorange | 108 | 1.3e-05 | 0.240 | 17 | GO:0043069 | BP | negative regulation of programmed cell death |
| 164 | darkorange | 108 | 2.5e-05 | 0.470 | 11 | GO:0052548 | BP | regulation of endopeptidase activity |
| 165 | darkorange | 108 | 4.0e-05 | 0.730 | 16 | GO:0043066 | BP | negative regulation of apoptotic process |
| 166 | darkorange | 108 | 4.3e-05 | 0.800 | 17 | GO:0060548 | BP | negative regulation of cell death |
| 167 | darkorange | 108 | 4.4e-05 | 0.810 | 11 | GO:0052547 | BP | regulation of peptidase activity |
| 168 | darkorange | 108 | 7.1e-05 | 1.000 | 8 | GO:2001234 | BP | negative regulation of apoptotic signaling pathway |
| 169 | darkorange | 108 | 1.3e-04 | 1.000 | 6 | GO:0043280 | BP | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| 170 | darkorange | 108 | 1.5e-04 | 1.000 | 2 | GO:0070460 | BP | thyroid-stimulating hormone secretion |
| 171 | darkorange2 | 65 | 3.0e-04 | 1.000 | 2 | GO:0017040 | MF | N-acylsphingosine amidohydrolase activity |
| 172 | darkorange2 | 65 | 1.1e-03 | 1.000 | 16 | GO:0042802 | MF | identical protein binding |
| 173 | darkorange2 | 65 | 1.3e-03 | 1.000 | 2 | GO:0046512 | BP | sphingosine biosynthetic process |
| 174 | darkorange2 | 65 | 1.3e-03 | 1.000 | 2 | GO:0046520 | BP | sphingoid biosynthetic process |
| 175 | darkorange2 | 65 | 1.4e-03 | 1.000 | 4 | GO:0002576 | BP | platelet degranulation |
| 176 | darkorange2 | 65 | 2.0e-03 | 1.000 | 2 | GO:0050710 | BP | negative regulation of cytokine secretion |
| 177 | darkorange2 | 65 | 2.0e-03 | 1.000 | 2 | GO:0051782 | BP | negative regulation of cell division |
| 178 | darkorange2 | 65 | 2.6e-03 | 1.000 | 2 | GO:0006670 | BP | sphingosine metabolic process |
| 179 | darkorange2 | 65 | 2.7e-03 | 1.000 | 3 | GO:0016811 | MF | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides |
| 180 | darkorange2 | 65 | 3.2e-03 | 1.000 | 2 | GO:0046514 | BP | ceramide catabolic process |
| 181 | darkred | 135 | 4.7e-04 | 1.000 | 2 | GO:2001137 | BP | positive regulation of endocytic recycling |
| 182 | darkred | 135 | 7.8e-04 | 1.000 | 5 | GO:0007229 | BP | integrin-mediated signaling pathway |
| 183 | darkred | 135 | 2.6e-03 | 1.000 | 3 | GO:0000217 | MF | DNA secondary structure binding |
| 184 | darkred | 135 | 2.7e-03 | 1.000 | 2 | GO:0006563 | BP | L-serine metabolic process |
| 185 | darkred | 135 | 2.7e-03 | 1.000 | 2 | GO:0032585 | CC | multivesicular body membrane |
| 186 | darkred | 135 | 3.4e-03 | 1.000 | 2 | GO:0051444 | BP | negative regulation of ubiquitin-protein transferase activity |
| 187 | darkred | 135 | 3.4e-03 | 1.000 | 2 | GO:2001135 | BP | regulation of endocytic recycling |
| 188 | darkred | 135 | 4.1e-03 | 1.000 | 2 | GO:0045651 | BP | positive regulation of macrophage differentiation |
| 189 | darkred | 135 | 4.1e-03 | 1.000 | 2 | GO:0070863 | BP | positive regulation of protein exit from endoplasmic reticulum |
| 190 | darkred | 135 | 4.1e-03 | 1.000 | 2 | GO:0005229 | MF | intracellular calcium activated chloride channel activity |
| 191 | darkseagreen4 | 40 | 3.0e-04 | 1.000 | 2 | GO:0046624 | MF | sphingolipid transporter activity |
| 192 | darkseagreen4 | 40 | 2.1e-03 | 1.000 | 3 | GO:0031398 | BP | positive regulation of protein ubiquitination |
| 193 | darkseagreen4 | 40 | 2.6e-03 | 1.000 | 1 | GO:1902225 | BP | negative regulation of acrosome reaction |
| 194 | darkseagreen4 | 40 | 2.6e-03 | 1.000 | 1 | GO:0031422 | CC | RecQ family helicase-topoisomerase III complex |
| 195 | darkseagreen4 | 40 | 2.6e-03 | 1.000 | 1 | GO:0003681 | MF | bent DNA binding |
| 196 | darkseagreen4 | 40 | 2.6e-03 | 1.000 | 1 | GO:0045352 | MF | interleukin-1 type I receptor antagonist activity |
| 197 | darkseagreen4 | 40 | 2.6e-03 | 1.000 | 1 | GO:0045353 | MF | interleukin-1 type II receptor antagonist activity |
| 198 | darkseagreen4 | 40 | 3.2e-03 | 1.000 | 2 | GO:0140223 | MF | general transcription initiation factor activity |
| 199 | darkseagreen4 | 40 | 4.0e-03 | 1.000 | 2 | GO:0001046 | MF | core promoter sequence-specific DNA binding |
| 200 | darkseagreen4 | 40 | 4.7e-03 | 1.000 | 3 | GO:0001959 | BP | regulation of cytokine-mediated signaling pathway |
| 201 | darkslateblue | 59 | 2.4e-04 | 1.000 | 2 | GO:0030314 | CC | junctional membrane complex |
| 202 | darkslateblue | 59 | 4.4e-04 | 1.000 | 2 | GO:0014701 | CC | junctional sarcoplasmic reticulum membrane |
| 203 | darkslateblue | 59 | 5.6e-04 | 1.000 | 2 | GO:0010960 | BP | magnesium ion homeostasis |
| 204 | darkslateblue | 59 | 5.6e-04 | 1.000 | 2 | GO:0060453 | BP | regulation of gastric acid secretion |
| 205 | darkslateblue | 59 | 1.2e-03 | 1.000 | 2 | GO:0001696 | BP | gastric acid secretion |
| 206 | darkslateblue | 59 | 1.3e-03 | 1.000 | 4 | GO:0055002 | BP | striated muscle cell development |
| 207 | darkslateblue | 59 | 1.5e-03 | 1.000 | 3 | GO:0016529 | CC | sarcoplasmic reticulum |
| 208 | darkslateblue | 59 | 1.9e-03 | 1.000 | 4 | GO:0055001 | BP | muscle cell development |
| 209 | darkslateblue | 59 | 2.1e-03 | 1.000 | 3 | GO:0016528 | CC | sarcoplasm |
| 210 | darkslateblue | 59 | 2.6e-03 | 1.000 | 2 | GO:1901380 | BP | negative regulation of potassium ion transmembrane transport |
| 211 | darkturquoise | 115 | 5.3e-04 | 1.000 | 5 | GO:0050868 | BP | negative regulation of T cell activation |
| 212 | darkturquoise | 115 | 6.1e-04 | 1.000 | 2 | GO:0071922 | BP | regulation of cohesin loading |
| 213 | darkturquoise | 115 | 7.6e-04 | 1.000 | 3 | GO:0004435 | MF | phosphatidylinositol phospholipase C activity |
| 214 | darkturquoise | 115 | 8.4e-04 | 1.000 | 5 | GO:1903038 | BP | negative regulation of leukocyte cell-cell adhesion |
| 215 | darkturquoise | 115 | 9.1e-04 | 1.000 | 2 | GO:0071921 | BP | cohesin loading |
| 216 | darkturquoise | 115 | 9.1e-04 | 1.000 | 2 | GO:1905634 | BP | regulation of protein localization to chromatin |
| 217 | darkturquoise | 115 | 9.7e-04 | 1.000 | 3 | GO:0005942 | CC | phosphatidylinositol 3-kinase complex |
| 218 | darkturquoise | 115 | 9.7e-04 | 1.000 | 3 | GO:0004629 | MF | phospholipase C activity |
| 219 | darkturquoise | 115 | 1.1e-03 | 1.000 | 8 | GO:0050863 | BP | regulation of T cell activation |
| 220 | darkturquoise | 115 | 1.5e-03 | 1.000 | 4 | GO:0035591 | MF | signaling adaptor activity |
| 221 | darkviolet | 28 | 1.8e-03 | 1.000 | 1 | GO:0015887 | BP | pantothenate transmembrane transport |
| 222 | darkviolet | 28 | 1.8e-03 | 1.000 | 1 | GO:1900170 | BP | negative regulation of glucocorticoid mediated signaling pathway |
| 223 | darkviolet | 28 | 1.8e-03 | 1.000 | 1 | GO:1902213 | BP | positive regulation of prolactin signaling pathway |
| 224 | darkviolet | 28 | 1.8e-03 | 1.000 | 1 | GO:1902440 | BP | protein localization to mitotic spindle pole body |
| 225 | darkviolet | 28 | 1.8e-03 | 1.000 | 1 | GO:0071540 | CC | eukaryotic translation initiation factor 3 complex, eIF3e |
| 226 | darkviolet | 28 | 1.8e-03 | 1.000 | 1 | GO:1990811 | CC | MWP complex |
| 227 | darkviolet | 28 | 1.8e-03 | 1.000 | 1 | GO:0008523 | MF | sodium-dependent multivitamin transmembrane transporter activity |
| 228 | darkviolet | 28 | 1.8e-03 | 1.000 | 1 | GO:0015233 | MF | pantothenate transmembrane transporter activity |
| 229 | darkviolet | 28 | 3.6e-03 | 1.000 | 1 | GO:0038018 | BP | Wnt receptor catabolic process |
| 230 | darkviolet | 28 | 3.6e-03 | 1.000 | 1 | GO:0038161 | BP | prolactin signaling pathway |
| 231 | firebrick4 | 28 | 1.9e-05 | 0.340 | 2 | GO:0034056 | MF | estrogen response element binding |
| 232 | firebrick4 | 28 | 4.7e-05 | 0.850 | 2 | GO:0070562 | BP | regulation of vitamin D receptor signaling pathway |
| 233 | firebrick4 | 28 | 1.1e-04 | 1.000 | 2 | GO:0070561 | BP | vitamin D receptor signaling pathway |
| 234 | firebrick4 | 28 | 5.2e-04 | 1.000 | 2 | GO:0071305 | BP | cellular response to vitamin D |
| 235 | firebrick4 | 28 | 6.0e-04 | 1.000 | 4 | GO:0030216 | BP | keratinocyte differentiation |
| 236 | firebrick4 | 28 | 1.1e-03 | 1.000 | 2 | GO:0071295 | BP | cellular response to vitamin |
| 237 | firebrick4 | 28 | 1.2e-03 | 1.000 | 4 | GO:0009913 | BP | epidermal cell differentiation |
| 238 | firebrick4 | 28 | 1.2e-03 | 1.000 | 2 | GO:0033280 | BP | response to vitamin D |
| 239 | firebrick4 | 28 | 1.8e-03 | 1.000 | 1 | GO:0003144 | BP | embryonic heart tube formation |
| 240 | firebrick4 | 28 | 1.8e-03 | 1.000 | 1 | GO:0006148 | BP | inosine catabolic process |
| 241 | floralwhite | 66 | 2.0e-05 | 0.370 | 2 | GO:0002352 | BP | B cell negative selection |
| 242 | floralwhite | 66 | 2.0e-05 | 0.370 | 2 | GO:0048597 | BP | post-embryonic camera-type eye morphogenesis |
| 243 | floralwhite | 66 | 2.0e-05 | 0.370 | 2 | GO:0097145 | CC | BAK complex |
| 244 | floralwhite | 66 | 1.2e-04 | 1.000 | 2 | GO:0046104 | BP | thymidine metabolic process |
| 245 | floralwhite | 66 | 1.2e-04 | 1.000 | 2 | GO:0106077 | BP | histone succinylation |
| 246 | floralwhite | 66 | 2.0e-04 | 1.000 | 2 | GO:0048050 | BP | post-embryonic eye morphogenesis |
| 247 | floralwhite | 66 | 2.0e-04 | 1.000 | 2 | GO:1902262 | BP | apoptotic process involved in blood vessel morphogenesis |
| 248 | floralwhite | 66 | 3.0e-04 | 1.000 | 2 | GO:0008635 | BP | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c |
| 249 | floralwhite | 66 | 3.0e-04 | 1.000 | 2 | GO:0031077 | BP | post-embryonic camera-type eye development |
| 250 | floralwhite | 66 | 3.0e-04 | 1.000 | 2 | GO:0045252 | CC | oxoglutarate dehydrogenase complex |
| 251 | green | 345 | 2.5e-05 | 0.470 | 6 | GO:0010765 | BP | positive regulation of sodium ion transport |
| 252 | green | 345 | 5.1e-04 | 1.000 | 2 | GO:0015680 | BP | protein maturation by copper ion transfer |
| 253 | green | 345 | 5.1e-04 | 1.000 | 2 | GO:0071879 | BP | positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway |
| 254 | green | 345 | 5.9e-04 | 1.000 | 3 | GO:0016139 | BP | glycoside catabolic process |
| 255 | green | 345 | 7.4e-04 | 1.000 | 13 | GO:0044242 | BP | cellular lipid catabolic process |
| 256 | green | 345 | 7.6e-04 | 1.000 | 4 | GO:1902307 | BP | positive regulation of sodium ion transmembrane transport |
| 257 | green | 345 | 7.7e-04 | 1.000 | 7 | GO:0002028 | BP | regulation of sodium ion transport |
| 258 | green | 345 | 8.7e-04 | 1.000 | 3 | GO:0035529 | MF | NADH pyrophosphatase activity |
| 259 | green | 345 | 8.8e-04 | 1.000 | 6 | GO:1902305 | BP | regulation of sodium ion transmembrane transport |
| 260 | green | 345 | 2.0e-03 | 1.000 | 5 | GO:0005544 | MF | calcium-dependent phospholipid binding |
| 261 | greenyellow | 195 | 2.0e-05 | 0.360 | 6 | GO:0034381 | BP | plasma lipoprotein particle clearance |
| 262 | greenyellow | 195 | 2.8e-04 | 1.000 | 6 | GO:0097006 | BP | regulation of plasma lipoprotein particle levels |
| 263 | greenyellow | 195 | 4.1e-04 | 1.000 | 10 | GO:0006898 | BP | receptor-mediated endocytosis |
| 264 | greenyellow | 195 | 4.1e-04 | 1.000 | 7 | GO:0007189 | BP | adenylate cyclase-activating G protein-coupled receptor signaling pathway |
| 265 | greenyellow | 195 | 2.4e-03 | 1.000 | 2 | GO:0010886 | BP | positive regulation of cholesterol storage |
| 266 | greenyellow | 195 | 3.1e-03 | 1.000 | 3 | GO:0010884 | BP | positive regulation of lipid storage |
| 267 | greenyellow | 195 | 3.3e-03 | 1.000 | 7 | GO:0019933 | BP | cAMP-mediated signaling |
| 268 | greenyellow | 195 | 3.3e-03 | 1.000 | 2 | GO:0000290 | BP | deadenylation-dependent decapping of nuclear-transcribed mRNA |
| 269 | greenyellow | 195 | 3.3e-03 | 1.000 | 2 | GO:0006573 | BP | valine metabolic process |
| 270 | greenyellow | 195 | 4.1e-03 | 1.000 | 4 | GO:0030888 | BP | regulation of B cell proliferation |
| 271 | grey | 3 | 2.1e-03 | 1.000 | 1 | GO:0051382 | BP | kinetochore assembly |
| 272 | grey | 3 | 2.8e-03 | 1.000 | 1 | GO:0051383 | BP | kinetochore organization |
| 273 | grey | 3 | 3.6e-03 | 1.000 | 1 | GO:0034080 | BP | CENP-A containing nucleosome assembly |
| 274 | grey | 3 | 4.4e-03 | 1.000 | 1 | GO:0006336 | BP | DNA replication-independent nucleosome assembly |
| 275 | grey | 3 | 4.6e-03 | 1.000 | 1 | GO:0034724 | BP | DNA replication-independent nucleosome organization |
| 276 | grey | 3 | 5.0e-03 | 1.000 | 1 | GO:0043486 | BP | histone exchange |
| 277 | grey | 3 | 5.1e-03 | 1.000 | 1 | GO:0034508 | BP | centromere complex assembly |
| 278 | grey | 3 | 7.5e-03 | 1.000 | 1 | GO:0043044 | BP | ATP-dependent chromatin remodeling |
| 279 | grey | 3 | 8.7e-03 | 1.000 | 1 | GO:0006334 | BP | nucleosome assembly |
| 280 | grey | 3 | 1.2e-02 | 1.000 | 1 | GO:0000777 | CC | condensed chromosome kinetochore |
| 281 | grey60 | 157 | 2.2e-05 | 0.410 | 3 | GO:2000391 | BP | positive regulation of neutrophil extravasation |
| 282 | grey60 | 157 | 3.9e-05 | 0.710 | 3 | GO:2000389 | BP | regulation of neutrophil extravasation |
| 283 | grey60 | 157 | 1.8e-04 | 1.000 | 3 | GO:0072672 | BP | neutrophil extravasation |
| 284 | grey60 | 157 | 5.8e-04 | 1.000 | 3 | GO:0002693 | BP | positive regulation of cellular extravasation |
| 285 | grey60 | 157 | 1.3e-03 | 1.000 | 8 | GO:0008514 | MF | organic anion transmembrane transporter activity |
| 286 | grey60 | 157 | 1.6e-03 | 1.000 | 2 | GO:2000347 | BP | positive regulation of hepatocyte proliferation |
| 287 | grey60 | 157 | 1.9e-03 | 1.000 | 9 | GO:0006520 | BP | cellular amino acid metabolic process |
| 288 | grey60 | 157 | 2.2e-03 | 1.000 | 5 | GO:0051082 | MF | unfolded protein binding |
| 289 | grey60 | 157 | 2.5e-03 | 1.000 | 3 | GO:0042910 | MF | xenobiotic transmembrane transporter activity |
| 290 | grey60 | 157 | 2.8e-03 | 1.000 | 3 | GO:0002691 | BP | regulation of cellular extravasation |
| 291 | honeydew1 | 52 | 3.8e-04 | 1.000 | 6 | GO:0045861 | BP | negative regulation of proteolysis |
| 292 | honeydew1 | 52 | 4.3e-04 | 1.000 | 5 | GO:0005085 | MF | guanyl-nucleotide exchange factor activity |
| 293 | honeydew1 | 52 | 4.7e-04 | 1.000 | 3 | GO:0032154 | CC | cleavage furrow |
| 294 | honeydew1 | 52 | 4.9e-04 | 1.000 | 41 | GO:0050794 | BP | regulation of cellular process |
| 295 | honeydew1 | 52 | 6.8e-04 | 1.000 | 3 | GO:0032153 | CC | cell division site |
| 296 | honeydew1 | 52 | 7.6e-04 | 1.000 | 2 | GO:0008191 | MF | metalloendopeptidase inhibitor activity |
| 297 | honeydew1 | 52 | 7.7e-04 | 1.000 | 7 | GO:0007264 | BP | small GTPase mediated signal transduction |
| 298 | honeydew1 | 52 | 1.4e-03 | 1.000 | 20 | GO:0098772 | MF | molecular function regulator |
| 299 | honeydew1 | 52 | 1.4e-03 | 1.000 | 4 | GO:0004866 | MF | endopeptidase inhibitor activity |
| 300 | honeydew1 | 52 | 1.5e-03 | 1.000 | 4 | GO:0030414 | MF | peptidase inhibitor activity |
| 301 | indianred4 | 28 | 3.0e-04 | 1.000 | 2 | GO:0048557 | BP | embryonic digestive tract morphogenesis |
| 302 | indianred4 | 28 | 8.3e-04 | 1.000 | 2 | GO:0002053 | BP | positive regulation of mesenchymal cell proliferation |
| 303 | indianred4 | 28 | 1.3e-03 | 1.000 | 3 | GO:0048565 | BP | digestive tract development |
| 304 | indianred4 | 28 | 1.4e-03 | 1.000 | 2 | GO:0048566 | BP | embryonic digestive tract development |
| 305 | indianred4 | 28 | 1.5e-03 | 1.000 | 2 | GO:0010464 | BP | regulation of mesenchymal cell proliferation |
| 306 | indianred4 | 28 | 1.7e-03 | 1.000 | 3 | GO:0055123 | BP | digestive system development |
| 307 | indianred4 | 28 | 1.9e-03 | 1.000 | 1 | GO:0030704 | BP | vitelline membrane formation |
| 308 | indianred4 | 28 | 1.9e-03 | 1.000 | 1 | GO:0035602 | BP | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell |
| 309 | indianred4 | 28 | 1.9e-03 | 1.000 | 1 | GO:0035603 | BP | fibroblast growth factor receptor signaling pathway involved in hemopoiesis |
| 310 | indianred4 | 28 | 1.9e-03 | 1.000 | 1 | GO:0035604 | BP | fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow |
| 311 | ivory | 70 | 9.4e-04 | 1.000 | 3 | GO:0008375 | MF | acetylglucosaminyltransferase activity |
| 312 | ivory | 70 | 1.2e-03 | 1.000 | 4 | GO:0042476 | BP | odontogenesis |
| 313 | ivory | 70 | 1.8e-03 | 1.000 | 3 | GO:0030173 | CC | integral component of Golgi membrane |
| 314 | ivory | 70 | 2.1e-03 | 1.000 | 3 | GO:0031228 | CC | intrinsic component of Golgi membrane |
| 315 | ivory | 70 | 4.3e-03 | 1.000 | 2 | GO:0016342 | CC | catenin complex |
| 316 | ivory | 70 | 4.5e-03 | 1.000 | 1 | GO:0006062 | BP | sorbitol catabolic process |
| 317 | ivory | 70 | 4.5e-03 | 1.000 | 1 | GO:0010070 | BP | zygote asymmetric cell division |
| 318 | ivory | 70 | 4.5e-03 | 1.000 | 1 | GO:0043143 | BP | regulation of translation by machinery localization |
| 319 | ivory | 70 | 4.5e-03 | 1.000 | 1 | GO:0051160 | BP | L-xylitol catabolic process |
| 320 | ivory | 70 | 4.5e-03 | 1.000 | 1 | GO:0051164 | BP | L-xylitol metabolic process |
| 321 | lavenderblush3 | 48 | 9.1e-05 | 1.000 | 5 | GO:0007416 | BP | synapse assembly |
| 322 | lavenderblush3 | 48 | 1.5e-04 | 1.000 | 2 | GO:0016272 | CC | prefoldin complex |
| 323 | lavenderblush3 | 48 | 5.4e-04 | 1.000 | 2 | GO:0098918 | MF | structural constituent of synapse |
| 324 | lavenderblush3 | 48 | 8.1e-04 | 1.000 | 4 | GO:0030307 | BP | positive regulation of cell growth |
| 325 | lavenderblush3 | 48 | 9.3e-04 | 1.000 | 6 | GO:0034329 | BP | cell junction assembly |
| 326 | lavenderblush3 | 48 | 1.1e-03 | 1.000 | 3 | GO:0005791 | CC | rough endoplasmic reticulum |
| 327 | lavenderblush3 | 48 | 2.0e-03 | 1.000 | 2 | GO:0070861 | BP | regulation of protein exit from endoplasmic reticulum |
| 328 | lavenderblush3 | 48 | 2.2e-03 | 1.000 | 8 | GO:0043549 | BP | regulation of kinase activity |
| 329 | lavenderblush3 | 48 | 2.2e-03 | 1.000 | 2 | GO:0010800 | BP | positive regulation of peptidyl-threonine phosphorylation |
| 330 | lavenderblush3 | 48 | 2.6e-03 | 1.000 | 4 | GO:0019207 | MF | kinase regulator activity |
| 331 | lightcoral | 38 | 3.1e-06 | 0.056 | 3 | GO:0021535 | BP | cell migration in hindbrain |
| 332 | lightcoral | 38 | 6.0e-06 | 0.110 | 2 | GO:0021934 | BP | hindbrain tangential cell migration |
| 333 | lightcoral | 38 | 6.0e-06 | 0.110 | 2 | GO:0021935 | BP | cerebellar granule cell precursor tangential migration |
| 334 | lightcoral | 38 | 4.6e-04 | 1.000 | 2 | GO:0045475 | BP | locomotor rhythm |
| 335 | lightcoral | 38 | 6.2e-04 | 1.000 | 2 | GO:0009263 | BP | deoxyribonucleotide biosynthetic process |
| 336 | lightcoral | 38 | 9.9e-04 | 1.000 | 3 | GO:0071013 | CC | catalytic step 2 spliceosome |
| 337 | lightcoral | 38 | 1.0e-03 | 1.000 | 3 | GO:0005684 | CC | U2-type spliceosomal complex |
| 338 | lightcoral | 38 | 2.0e-03 | 1.000 | 2 | GO:0046966 | MF | thyroid hormone receptor binding |
| 339 | lightcoral | 38 | 2.2e-03 | 1.000 | 6 | GO:0051640 | BP | organelle localization |
| 340 | lightcoral | 38 | 2.3e-03 | 1.000 | 2 | GO:0071007 | CC | U2-type catalytic step 2 spliceosome |
| 341 | lightcyan | 165 | 1.2e-04 | 1.000 | 2 | GO:0043813 | MF | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity |
| 342 | lightcyan | 165 | 3.5e-04 | 1.000 | 3 | GO:0036092 | BP | phosphatidylinositol-3-phosphate biosynthetic process |
| 343 | lightcyan | 165 | 3.6e-04 | 1.000 | 2 | GO:0021530 | BP | spinal cord oligodendrocyte cell fate specification |
| 344 | lightcyan | 165 | 3.6e-04 | 1.000 | 2 | GO:0033600 | BP | negative regulation of mammary gland epithelial cell proliferation |
| 345 | lightcyan | 165 | 4.9e-04 | 1.000 | 67 | GO:0007275 | BP | multicellular organism development |
| 346 | lightcyan | 165 | 6.7e-04 | 1.000 | 3 | GO:0033599 | BP | regulation of mammary gland epithelial cell proliferation |
| 347 | lightcyan | 165 | 7.2e-04 | 1.000 | 2 | GO:0035799 | BP | ureter maturation |
| 348 | lightcyan | 165 | 7.2e-04 | 1.000 | 2 | GO:0005134 | MF | interleukin-2 receptor binding |
| 349 | lightcyan | 165 | 8.0e-04 | 1.000 | 16 | GO:0045596 | BP | negative regulation of cell differentiation |
| 350 | lightcyan | 165 | 8.4e-04 | 1.000 | 19 | GO:0051960 | BP | regulation of nervous system development |
| 351 | lightcyan1 | 72 | 1.2e-03 | 1.000 | 8 | GO:0007264 | BP | small GTPase mediated signal transduction |
| 352 | lightcyan1 | 72 | 1.3e-03 | 1.000 | 4 | GO:0005088 | MF | Ras guanyl-nucleotide exchange factor activity |
| 353 | lightcyan1 | 72 | 2.1e-03 | 1.000 | 3 | GO:0005089 | MF | Rho guanyl-nucleotide exchange factor activity |
| 354 | lightcyan1 | 72 | 2.1e-03 | 1.000 | 31 | GO:0005886 | CC | plasma membrane |
| 355 | lightcyan1 | 72 | 2.3e-03 | 1.000 | 5 | GO:0043491 | BP | protein kinase B signaling |
| 356 | lightcyan1 | 72 | 3.0e-03 | 1.000 | 31 | GO:0071944 | CC | cell periphery |
| 357 | lightcyan1 | 72 | 3.1e-03 | 1.000 | 11 | GO:0007186 | BP | G protein-coupled receptor signaling pathway |
| 358 | lightcyan1 | 72 | 3.4e-03 | 1.000 | 4 | GO:0051897 | BP | positive regulation of protein kinase B signaling |
| 359 | lightcyan1 | 72 | 3.9e-03 | 1.000 | 7 | GO:0010975 | BP | regulation of neuron projection development |
| 360 | lightcyan1 | 72 | 4.0e-03 | 1.000 | 2 | GO:0097205 | BP | renal filtration |
| 361 | lightgreen | 161 | 9.9e-04 | 1.000 | 4 | GO:0070849 | BP | response to epidermal growth factor |
| 362 | lightgreen | 161 | 1.7e-03 | 1.000 | 4 | GO:0032206 | BP | positive regulation of telomere maintenance |
| 363 | lightgreen | 161 | 2.4e-03 | 1.000 | 14 | GO:0008134 | MF | transcription factor binding |
| 364 | lightgreen | 161 | 2.4e-03 | 1.000 | 2 | GO:0016803 | MF | ether hydrolase activity |
| 365 | lightgreen | 161 | 2.4e-03 | 1.000 | 2 | GO:0017151 | MF | DEAD/H-box RNA helicase binding |
| 366 | lightgreen | 161 | 3.0e-03 | 1.000 | 3 | GO:0004693 | MF | cyclin-dependent protein serine/threonine kinase activity |
| 367 | lightgreen | 161 | 3.0e-03 | 1.000 | 3 | GO:0097472 | MF | cyclin-dependent protein kinase activity |
| 368 | lightgreen | 161 | 3.1e-03 | 1.000 | 10 | GO:0002768 | BP | immune response-regulating cell surface receptor signaling pathway |
| 369 | lightgreen | 161 | 3.1e-03 | 1.000 | 2 | GO:0051121 | BP | hepoxilin metabolic process |
| 370 | lightgreen | 161 | 3.1e-03 | 1.000 | 2 | GO:0051122 | BP | hepoxilin biosynthetic process |
| 371 | lightpink4 | 51 | 1.8e-03 | 1.000 | 2 | GO:0097038 | CC | perinuclear endoplasmic reticulum |
| 372 | lightpink4 | 51 | 2.4e-03 | 1.000 | 2 | GO:0006706 | BP | steroid catabolic process |
| 373 | lightpink4 | 51 | 3.3e-03 | 1.000 | 1 | GO:0009403 | BP | toxin biosynthetic process |
| 374 | lightpink4 | 51 | 3.3e-03 | 1.000 | 1 | GO:0031583 | BP | phospholipase D-activating G protein-coupled receptor signaling pathway |
| 375 | lightpink4 | 51 | 3.3e-03 | 1.000 | 1 | GO:0034696 | BP | response to prostaglandin F |
| 376 | lightpink4 | 51 | 3.3e-03 | 1.000 | 1 | GO:0042313 | BP | protein kinase C deactivation |
| 377 | lightpink4 | 51 | 3.3e-03 | 1.000 | 1 | GO:0043179 | BP | rhythmic excitation |
| 378 | lightpink4 | 51 | 3.3e-03 | 1.000 | 1 | GO:0071615 | BP | oxidative deethylation |
| 379 | lightpink4 | 51 | 3.3e-03 | 1.000 | 1 | GO:0097117 | BP | guanylate kinase-associated protein clustering |
| 380 | lightpink4 | 51 | 3.3e-03 | 1.000 | 1 | GO:0097323 | BP | B cell adhesion |
| 381 | lightsteelblue | 36 | 1.1e-05 | 0.200 | 6 | GO:0000082 | BP | G1/S transition of mitotic cell cycle |
| 382 | lightsteelblue | 36 | 1.5e-05 | 0.280 | 6 | GO:0044843 | BP | cell cycle G1/S phase transition |
| 383 | lightsteelblue | 36 | 1.6e-04 | 1.000 | 5 | GO:0072331 | BP | signal transduction by p53 class mediator |
| 384 | lightsteelblue | 36 | 3.7e-04 | 1.000 | 4 | GO:1901796 | BP | regulation of signal transduction by p53 class mediator |
| 385 | lightsteelblue | 36 | 5.1e-04 | 1.000 | 3 | GO:0021954 | BP | central nervous system neuron development |
| 386 | lightsteelblue | 36 | 5.2e-04 | 1.000 | 2 | GO:0005540 | MF | hyaluronic acid binding |
| 387 | lightsteelblue | 36 | 6.8e-04 | 1.000 | 3 | GO:0021549 | BP | cerebellum development |
| 388 | lightsteelblue | 36 | 7.3e-04 | 1.000 | 6 | GO:0044772 | BP | mitotic cell cycle phase transition |
| 389 | lightsteelblue | 36 | 9.0e-04 | 1.000 | 6 | GO:0045786 | BP | negative regulation of cell cycle |
| 390 | lightsteelblue | 36 | 9.4e-04 | 1.000 | 3 | GO:0022037 | BP | metencephalon development |
| 391 | lightsteelblue1 | 76 | 1.6e-04 | 1.000 | 2 | GO:0000019 | BP | regulation of mitotic recombination |
| 392 | lightsteelblue1 | 76 | 9.4e-04 | 1.000 | 2 | GO:0014894 | BP | response to denervation involved in regulation of muscle adaptation |
| 393 | lightsteelblue1 | 76 | 9.4e-04 | 1.000 | 2 | GO:0001162 | MF | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding |
| 394 | lightsteelblue1 | 76 | 1.2e-03 | 1.000 | 2 | GO:0014870 | BP | response to muscle inactivity |
| 395 | lightsteelblue1 | 76 | 1.4e-03 | 1.000 | 2 | GO:0001161 | MF | intronic transcription regulatory region sequence-specific DNA binding |
| 396 | lightsteelblue1 | 76 | 1.7e-03 | 1.000 | 2 | GO:0014854 | BP | response to inactivity |
| 397 | lightsteelblue1 | 76 | 1.7e-03 | 1.000 | 2 | GO:0016290 | MF | palmitoyl-CoA hydrolase activity |
| 398 | lightsteelblue1 | 76 | 1.7e-03 | 1.000 | 2 | GO:0034236 | MF | protein kinase A catalytic subunit binding |
| 399 | lightsteelblue1 | 76 | 3.0e-03 | 1.000 | 2 | GO:0047617 | MF | acyl-CoA hydrolase activity |
| 400 | lightsteelblue1 | 76 | 3.9e-03 | 1.000 | 2 | GO:0016289 | MF | CoA hydrolase activity |
| 401 | lightyellow | 139 | 2.2e-04 | 1.000 | 46 | GO:0098772 | MF | molecular function regulator |
| 402 | lightyellow | 139 | 2.6e-04 | 1.000 | 2 | GO:1902268 | BP | negative regulation of polyamine transmembrane transport |
| 403 | lightyellow | 139 | 2.6e-04 | 1.000 | 2 | GO:0008073 | MF | ornithine decarboxylase inhibitor activity |
| 404 | lightyellow | 139 | 5.2e-04 | 1.000 | 2 | GO:0061009 | BP | common bile duct development |
| 405 | lightyellow | 139 | 1.3e-03 | 1.000 | 2 | GO:1902047 | BP | polyamine transmembrane transport |
| 406 | lightyellow | 139 | 1.6e-03 | 1.000 | 27 | GO:0140110 | MF | transcription regulator activity |
| 407 | lightyellow | 139 | 1.8e-03 | 1.000 | 2 | GO:0006729 | BP | tetrahydrobiopterin biosynthetic process |
| 408 | lightyellow | 139 | 3.3e-03 | 1.000 | 4 | GO:0099601 | BP | regulation of neurotransmitter receptor activity |
| 409 | lightyellow | 139 | 4.3e-03 | 1.000 | 3 | GO:0001709 | BP | cell fate determination |
| 410 | lightyellow | 139 | 6.4e-03 | 1.000 | 2 | GO:0006596 | BP | polyamine biosynthetic process |
| 411 | magenta | 206 | 6.9e-06 | 0.130 | 13 | GO:0016323 | CC | basolateral plasma membrane |
| 412 | magenta | 206 | 1.9e-04 | 1.000 | 2 | GO:0008396 | MF | oxysterol 7-alpha-hydroxylase activity |
| 413 | magenta | 206 | 9.9e-04 | 1.000 | 12 | GO:0016324 | CC | apical plasma membrane |
| 414 | magenta | 206 | 1.0e-03 | 1.000 | 3 | GO:0015174 | MF | basic amino acid transmembrane transporter activity |
| 415 | magenta | 206 | 1.3e-03 | 1.000 | 3 | GO:0006704 | BP | glucocorticoid biosynthetic process |
| 416 | magenta | 206 | 1.3e-03 | 1.000 | 3 | GO:0015802 | BP | basic amino acid transport |
| 417 | magenta | 206 | 1.7e-03 | 1.000 | 13 | GO:0045177 | CC | apical part of cell |
| 418 | magenta | 206 | 1.8e-03 | 1.000 | 2 | GO:0031947 | BP | negative regulation of glucocorticoid biosynthetic process |
| 419 | magenta | 206 | 1.8e-03 | 1.000 | 2 | GO:0005290 | MF | L-histidine transmembrane transporter activity |
| 420 | magenta | 206 | 2.5e-03 | 1.000 | 3 | GO:0008211 | BP | glucocorticoid metabolic process |
| 421 | maroon | 54 | 3.4e-05 | 0.630 | 6 | GO:0019867 | CC | outer membrane |
| 422 | maroon | 54 | 4.0e-04 | 1.000 | 4 | GO:0004197 | MF | cysteine-type endopeptidase activity |
| 423 | maroon | 54 | 4.2e-04 | 1.000 | 3 | GO:0006654 | BP | phosphatidic acid biosynthetic process |
| 424 | maroon | 54 | 4.8e-04 | 1.000 | 3 | GO:0046473 | BP | phosphatidic acid metabolic process |
| 425 | maroon | 54 | 7.1e-04 | 1.000 | 2 | GO:0044214 | CC | spanning component of plasma membrane |
| 426 | maroon | 54 | 7.1e-04 | 1.000 | 2 | GO:0047498 | MF | calcium-dependent phospholipase A2 activity |
| 427 | maroon | 54 | 8.3e-04 | 1.000 | 4 | GO:0008234 | MF | cysteine-type peptidase activity |
| 428 | maroon | 54 | 1.2e-03 | 1.000 | 2 | GO:0036148 | BP | phosphatidylglycerol acyl-chain remodeling |
| 429 | maroon | 54 | 1.2e-03 | 1.000 | 2 | GO:0036149 | BP | phosphatidylinositol acyl-chain remodeling |
| 430 | maroon | 54 | 1.3e-03 | 1.000 | 2 | GO:0102567 | MF | phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) |
| 431 | mediumorchid | 37 | 2.3e-03 | 1.000 | 2 | GO:1902230 | BP | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
| 432 | mediumorchid | 37 | 2.6e-03 | 1.000 | 1 | GO:0038041 | BP | cross-receptor inhibition within G protein-coupled receptor heterodimer |
| 433 | mediumorchid | 37 | 2.6e-03 | 1.000 | 1 | GO:0070889 | BP | platelet alpha granule organization |
| 434 | mediumorchid | 37 | 2.6e-03 | 1.000 | 1 | GO:1905665 | BP | positive regulation of calcium ion import across plasma membrane |
| 435 | mediumorchid | 37 | 2.6e-03 | 1.000 | 1 | GO:0002144 | CC | cytosolic tRNA wobble base thiouridylase complex |
| 436 | mediumorchid | 37 | 2.6e-03 | 1.000 | 1 | GO:0031260 | CC | pseudopodium membrane |
| 437 | mediumorchid | 37 | 2.6e-03 | 1.000 | 1 | GO:0031592 | CC | centrosomal corona |
| 438 | mediumorchid | 37 | 2.6e-03 | 1.000 | 1 | GO:0150058 | CC | amylin receptor complex 3 |
| 439 | mediumorchid | 37 | 2.6e-03 | 1.000 | 1 | GO:1903143 | CC | adrenomedullin receptor complex |
| 440 | mediumorchid | 37 | 2.6e-03 | 1.000 | 1 | GO:0001605 | MF | adrenomedullin receptor activity |
| 441 | mediumpurple2 | 36 | 9.0e-04 | 1.000 | 2 | GO:0010954 | BP | positive regulation of protein processing |
| 442 | mediumpurple2 | 36 | 9.9e-04 | 1.000 | 2 | GO:1903319 | BP | positive regulation of protein maturation |
| 443 | mediumpurple2 | 36 | 2.4e-03 | 1.000 | 1 | GO:0036114 | BP | medium-chain fatty-acyl-CoA catabolic process |
| 444 | mediumpurple2 | 36 | 2.4e-03 | 1.000 | 1 | GO:0036116 | BP | long-chain fatty-acyl-CoA catabolic process |
| 445 | mediumpurple2 | 36 | 2.4e-03 | 1.000 | 1 | GO:0039654 | BP | fusion of virus membrane with host endosome membrane |
| 446 | mediumpurple2 | 36 | 2.4e-03 | 1.000 | 1 | GO:0060168 | BP | positive regulation of adenosine receptor signaling pathway |
| 447 | mediumpurple2 | 36 | 2.4e-03 | 1.000 | 1 | GO:0071206 | BP | establishment of protein localization to juxtaparanode region of axon |
| 448 | mediumpurple2 | 36 | 2.4e-03 | 1.000 | 1 | GO:0080163 | BP | regulation of protein serine/threonine phosphatase activity |
| 449 | mediumpurple2 | 36 | 2.4e-03 | 1.000 | 1 | GO:0085032 | BP | modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade |
| 450 | mediumpurple2 | 36 | 2.4e-03 | 1.000 | 1 | GO:1900535 | BP | palmitic acid biosynthetic process |
| 451 | mediumpurple3 | 78 | 1.8e-03 | 1.000 | 2 | GO:0090594 | BP | inflammatory response to wounding |
| 452 | mediumpurple3 | 78 | 1.8e-03 | 1.000 | 2 | GO:0008569 | MF | ATP-dependent microtubule motor activity, minus-end-directed |
| 453 | mediumpurple3 | 78 | 1.8e-03 | 1.000 | 2 | GO:0097153 | MF | cysteine-type endopeptidase activity involved in apoptotic process |
| 454 | mediumpurple3 | 78 | 2.9e-03 | 1.000 | 2 | GO:0046625 | MF | sphingolipid binding |
| 455 | mediumpurple3 | 78 | 4.2e-03 | 1.000 | 6 | GO:0007018 | BP | microtubule-based movement |
| 456 | mediumpurple3 | 78 | 5.4e-03 | 1.000 | 1 | GO:0010189 | BP | vitamin E biosynthetic process |
| 457 | mediumpurple3 | 78 | 5.4e-03 | 1.000 | 1 | GO:0042941 | BP | D-alanine transport |
| 458 | mediumpurple3 | 78 | 5.4e-03 | 1.000 | 1 | GO:0072377 | BP | blood coagulation, common pathway |
| 459 | mediumpurple3 | 78 | 5.4e-03 | 1.000 | 1 | GO:0072382 | BP | minus-end-directed vesicle transport along microtubule |
| 460 | mediumpurple3 | 78 | 5.4e-03 | 1.000 | 1 | GO:2001111 | BP | positive regulation of lens epithelial cell proliferation |
| 461 | midnightblue | 169 | 7.2e-04 | 1.000 | 6 | GO:0016779 | MF | nucleotidyltransferase activity |
| 462 | midnightblue | 169 | 8.8e-04 | 1.000 | 3 | GO:0045723 | BP | positive regulation of fatty acid biosynthetic process |
| 463 | midnightblue | 169 | 1.1e-03 | 1.000 | 4 | GO:0042304 | BP | regulation of fatty acid biosynthetic process |
| 464 | midnightblue | 169 | 1.7e-03 | 1.000 | 3 | GO:0042575 | CC | DNA polymerase complex |
| 465 | midnightblue | 169 | 2.2e-03 | 1.000 | 3 | GO:0007026 | BP | negative regulation of microtubule depolymerization |
| 466 | midnightblue | 169 | 3.5e-03 | 1.000 | 3 | GO:0031114 | BP | regulation of microtubule depolymerization |
| 467 | midnightblue | 169 | 5.2e-03 | 1.000 | 3 | GO:0045923 | BP | positive regulation of fatty acid metabolic process |
| 468 | midnightblue | 169 | 5.5e-03 | 1.000 | 2 | GO:0051152 | BP | positive regulation of smooth muscle cell differentiation |
| 469 | midnightblue | 169 | 6.7e-03 | 1.000 | 2 | GO:0000028 | BP | ribosomal small subunit assembly |
| 470 | midnightblue | 169 | 6.8e-03 | 1.000 | 3 | GO:0031111 | BP | negative regulation of microtubule polymerization or depolymerization |
| 471 | navajowhite2 | 48 | 3.1e-05 | 0.570 | 2 | GO:0010724 | BP | regulation of definitive erythrocyte differentiation |
| 472 | navajowhite2 | 48 | 1.0e-04 | 1.000 | 2 | GO:0060318 | BP | definitive erythrocyte differentiation |
| 473 | navajowhite2 | 48 | 2.9e-04 | 1.000 | 2 | GO:0071374 | BP | cellular response to parathyroid hormone stimulus |
| 474 | navajowhite2 | 48 | 3.0e-04 | 1.000 | 7 | GO:0005635 | CC | nuclear envelope |
| 475 | navajowhite2 | 48 | 4.6e-04 | 1.000 | 2 | GO:0071107 | BP | response to parathyroid hormone |
| 476 | navajowhite2 | 48 | 6.7e-04 | 1.000 | 2 | GO:0014029 | BP | neural crest formation |
| 477 | navajowhite2 | 48 | 1.0e-03 | 1.000 | 7 | GO:0005929 | CC | cilium |
| 478 | navajowhite2 | 48 | 1.4e-03 | 1.000 | 5 | GO:0031965 | CC | nuclear membrane |
| 479 | navajowhite2 | 48 | 1.5e-03 | 1.000 | 3 | GO:0042775 | BP | mitochondrial ATP synthesis coupled electron transport |
| 480 | navajowhite2 | 48 | 1.5e-03 | 1.000 | 3 | GO:0042773 | BP | ATP synthesis coupled electron transport |
| 481 | orange | 116 | 2.7e-04 | 1.000 | 3 | GO:1902165 | BP | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
| 482 | orange | 116 | 4.2e-04 | 1.000 | 5 | GO:0032587 | CC | ruffle membrane |
| 483 | orange | 116 | 8.7e-04 | 1.000 | 3 | GO:1902253 | BP | regulation of intrinsic apoptotic signaling pathway by p53 class mediator |
| 484 | orange | 116 | 1.6e-03 | 1.000 | 2 | GO:1903977 | BP | positive regulation of glial cell migration |
| 485 | orange | 116 | 2.2e-03 | 1.000 | 3 | GO:0097178 | BP | ruffle assembly |
| 486 | orange | 116 | 2.5e-03 | 1.000 | 2 | GO:0015347 | MF | sodium-independent organic anion transmembrane transporter activity |
| 487 | orange | 116 | 2.7e-03 | 1.000 | 8 | GO:0006869 | BP | lipid transport |
| 488 | orange | 116 | 3.0e-03 | 1.000 | 2 | GO:0032536 | BP | regulation of cell projection size |
| 489 | orange | 116 | 3.0e-03 | 1.000 | 2 | GO:0043252 | BP | sodium-independent organic anion transport |
| 490 | orange | 116 | 3.0e-03 | 1.000 | 2 | GO:0097001 | MF | ceramide binding |
| 491 | orangered3 | 39 | 8.3e-04 | 1.000 | 2 | GO:0046426 | BP | negative regulation of receptor signaling pathway via JAK-STAT |
| 492 | orangered3 | 39 | 9.4e-04 | 1.000 | 2 | GO:1904893 | BP | negative regulation of receptor signaling pathway via STAT |
| 493 | orangered3 | 39 | 2.7e-03 | 1.000 | 1 | GO:0036305 | BP | ameloblast differentiation |
| 494 | orangered3 | 39 | 2.7e-03 | 1.000 | 1 | GO:0051685 | BP | maintenance of ER location |
| 495 | orangered3 | 39 | 2.7e-03 | 1.000 | 1 | GO:0070175 | BP | positive regulation of enamel mineralization |
| 496 | orangered3 | 39 | 2.7e-03 | 1.000 | 1 | GO:0072355 | BP | histone H3-T3 phosphorylation |
| 497 | orangered3 | 39 | 2.7e-03 | 1.000 | 1 | GO:1904108 | BP | protein localization to ciliary inversin compartment |
| 498 | orangered3 | 39 | 2.7e-03 | 1.000 | 1 | GO:1904313 | BP | response to methamphetamine hydrochloride |
| 499 | orangered3 | 39 | 2.7e-03 | 1.000 | 1 | GO:1904935 | BP | positive regulation of cell proliferation in midbrain |
| 500 | orangered3 | 39 | 2.7e-03 | 1.000 | 1 | GO:1990792 | BP | cellular response to glial cell derived neurotrophic factor |
| 501 | orangered4 | 80 | 6.1e-05 | 1.000 | 3 | GO:0006047 | BP | UDP-N-acetylglucosamine metabolic process |
| 502 | orangered4 | 80 | 1.6e-04 | 1.000 | 2 | GO:0006041 | BP | glucosamine metabolic process |
| 503 | orangered4 | 80 | 3.2e-04 | 1.000 | 5 | GO:0015079 | MF | potassium ion transmembrane transporter activity |
| 504 | orangered4 | 80 | 4.0e-04 | 1.000 | 2 | GO:1903862 | BP | positive regulation of oxidative phosphorylation |
| 505 | orangered4 | 80 | 6.8e-04 | 1.000 | 3 | GO:0009225 | BP | nucleotide-sugar metabolic process |
| 506 | orangered4 | 80 | 1.0e-03 | 1.000 | 4 | GO:0005267 | MF | potassium channel activity |
| 507 | orangered4 | 80 | 1.2e-03 | 1.000 | 2 | GO:0006048 | BP | UDP-N-acetylglucosamine biosynthetic process |
| 508 | orangered4 | 80 | 1.6e-03 | 1.000 | 7 | GO:0046873 | MF | metal ion transmembrane transporter activity |
| 509 | orangered4 | 80 | 2.1e-03 | 1.000 | 8 | GO:0022890 | MF | inorganic cation transmembrane transporter activity |
| 510 | orangered4 | 80 | 3.1e-03 | 1.000 | 2 | GO:2001169 | BP | regulation of ATP biosynthetic process |
| 511 | paleturquoise | 86 | 4.8e-05 | 0.890 | 3 | GO:0042613 | CC | MHC class II protein complex |
| 512 | paleturquoise | 86 | 1.0e-04 | 1.000 | 4 | GO:0045334 | CC | clathrin-coated endocytic vesicle |
| 513 | paleturquoise | 86 | 1.9e-04 | 1.000 | 2 | GO:0015811 | BP | L-cystine transport |
| 514 | paleturquoise | 86 | 1.9e-04 | 1.000 | 2 | GO:0015184 | MF | L-cystine transmembrane transporter activity |
| 515 | paleturquoise | 86 | 2.2e-04 | 1.000 | 3 | GO:0071556 | CC | integral component of lumenal side of endoplasmic reticulum membrane |
| 516 | paleturquoise | 86 | 2.2e-04 | 1.000 | 3 | GO:0042605 | MF | peptide antigen binding |
| 517 | paleturquoise | 86 | 3.7e-04 | 1.000 | 3 | GO:0098576 | CC | lumenal side of membrane |
| 518 | paleturquoise | 86 | 7.1e-04 | 1.000 | 3 | GO:0030669 | CC | clathrin-coated endocytic vesicle membrane |
| 519 | paleturquoise | 86 | 8.2e-04 | 1.000 | 4 | GO:0032588 | CC | trans-Golgi network membrane |
| 520 | paleturquoise | 86 | 8.7e-04 | 1.000 | 2 | GO:0032395 | MF | MHC class II receptor activity |
| 521 | palevioletred3 | 54 | 7.1e-04 | 1.000 | 3 | GO:0042130 | BP | negative regulation of T cell proliferation |
| 522 | palevioletred3 | 54 | 7.2e-04 | 1.000 | 5 | GO:0070663 | BP | regulation of leukocyte proliferation |
| 523 | palevioletred3 | 54 | 7.5e-04 | 1.000 | 4 | GO:0022612 | BP | gland morphogenesis |
| 524 | palevioletred3 | 54 | 1.0e-03 | 1.000 | 4 | GO:0008083 | MF | growth factor activity |
| 525 | palevioletred3 | 54 | 1.2e-03 | 1.000 | 2 | GO:0002295 | BP | T-helper cell lineage commitment |
| 526 | palevioletred3 | 54 | 1.4e-03 | 1.000 | 3 | GO:0050672 | BP | negative regulation of lymphocyte proliferation |
| 527 | palevioletred3 | 54 | 1.5e-03 | 1.000 | 3 | GO:0032945 | BP | negative regulation of mononuclear cell proliferation |
| 528 | palevioletred3 | 54 | 1.5e-03 | 1.000 | 4 | GO:0042129 | BP | regulation of T cell proliferation |
| 529 | palevioletred3 | 54 | 1.6e-03 | 1.000 | 2 | GO:0072574 | BP | hepatocyte proliferation |
| 530 | palevioletred3 | 54 | 1.6e-03 | 1.000 | 3 | GO:0061180 | BP | mammary gland epithelium development |
| 531 | pink | 271 | 3.3e-04 | 1.000 | 2 | GO:0048203 | BP | vesicle targeting, trans-Golgi to endosome |
| 532 | pink | 271 | 3.3e-04 | 1.000 | 2 | GO:1990402 | BP | embryonic liver development |
| 533 | pink | 271 | 6.4e-04 | 1.000 | 3 | GO:0071600 | BP | otic vesicle morphogenesis |
| 534 | pink | 271 | 9.6e-04 | 1.000 | 2 | GO:0030538 | BP | embryonic genitalia morphogenesis |
| 535 | pink | 271 | 1.8e-03 | 1.000 | 3 | GO:0071599 | BP | otic vesicle development |
| 536 | pink | 271 | 1.9e-03 | 1.000 | 2 | GO:0010641 | BP | positive regulation of platelet-derived growth factor receptor signaling pathway |
| 537 | pink | 271 | 1.9e-03 | 1.000 | 2 | GO:0043932 | BP | ossification involved in bone remodeling |
| 538 | pink | 271 | 1.9e-03 | 1.000 | 2 | GO:1900069 | BP | regulation of cellular hyperosmotic salinity response |
| 539 | pink | 271 | 2.2e-03 | 1.000 | 4 | GO:0030212 | BP | hyaluronan metabolic process |
| 540 | pink | 271 | 2.3e-03 | 1.000 | 3 | GO:0005540 | MF | hyaluronic acid binding |
| 541 | plum | 32 | 3.0e-04 | 1.000 | 5 | GO:0009615 | BP | response to virus |
| 542 | plum | 32 | 4.3e-04 | 1.000 | 3 | GO:1901224 | BP | positive regulation of NIK/NF-kappaB signaling |
| 543 | plum | 32 | 4.5e-04 | 1.000 | 3 | GO:0003725 | MF | double-stranded RNA binding |
| 544 | plum | 32 | 5.1e-04 | 1.000 | 3 | GO:0032755 | BP | positive regulation of interleukin-6 production |
| 545 | plum | 32 | 7.1e-04 | 1.000 | 2 | GO:0032727 | BP | positive regulation of interferon-alpha production |
| 546 | plum | 32 | 7.4e-04 | 1.000 | 7 | GO:0045087 | BP | innate immune response |
| 547 | plum | 32 | 9.7e-04 | 1.000 | 2 | GO:0032607 | BP | interferon-alpha production |
| 548 | plum | 32 | 1.1e-03 | 1.000 | 3 | GO:1901222 | BP | regulation of NIK/NF-kappaB signaling |
| 549 | plum | 32 | 1.1e-03 | 1.000 | 3 | GO:0035821 | BP | modulation of process of other organism |
| 550 | plum | 32 | 1.1e-03 | 1.000 | 4 | GO:0051607 | BP | defense response to virus |
| 551 | plum1 | 84 | 4.7e-04 | 1.000 | 10 | GO:0003682 | MF | chromatin binding |
| 552 | plum1 | 84 | 8.9e-04 | 1.000 | 2 | GO:0034144 | BP | negative regulation of toll-like receptor 4 signaling pathway |
| 553 | plum1 | 84 | 1.3e-03 | 1.000 | 3 | GO:0032266 | MF | phosphatidylinositol-3-phosphate binding |
| 554 | plum1 | 84 | 2.1e-03 | 1.000 | 2 | GO:0018158 | BP | protein oxidation |
| 555 | plum1 | 84 | 2.3e-03 | 1.000 | 5 | GO:0003714 | MF | transcription corepressor activity |
| 556 | plum1 | 84 | 2.4e-03 | 1.000 | 2 | GO:0043970 | BP | histone H3-K9 acetylation |
| 557 | plum1 | 84 | 2.4e-03 | 1.000 | 2 | GO:2000232 | BP | regulation of rRNA processing |
| 558 | plum1 | 84 | 3.3e-03 | 1.000 | 2 | GO:2001224 | BP | positive regulation of neuron migration |
| 559 | plum1 | 84 | 3.7e-03 | 1.000 | 2 | GO:0031065 | BP | positive regulation of histone deacetylation |
| 560 | plum1 | 84 | 3.7e-03 | 1.000 | 2 | GO:0060396 | BP | growth hormone receptor signaling pathway |
| 561 | plum2 | 60 | 2.4e-04 | 1.000 | 2 | GO:0004691 | MF | cAMP-dependent protein kinase activity |
| 562 | plum2 | 60 | 4.4e-04 | 1.000 | 2 | GO:0033018 | CC | sarcoplasmic reticulum lumen |
| 563 | plum2 | 60 | 1.4e-03 | 1.000 | 2 | GO:0031000 | BP | response to caffeine |
| 564 | plum2 | 60 | 2.6e-03 | 1.000 | 6 | GO:0006874 | BP | cellular calcium ion homeostasis |
| 565 | plum2 | 60 | 2.9e-03 | 1.000 | 5 | GO:0005788 | CC | endoplasmic reticulum lumen |
| 566 | plum2 | 60 | 3.0e-03 | 1.000 | 6 | GO:0055074 | BP | calcium ion homeostasis |
| 567 | plum2 | 60 | 3.8e-03 | 1.000 | 8 | GO:0055082 | BP | cellular chemical homeostasis |
| 568 | plum2 | 60 | 4.0e-03 | 1.000 | 1 | GO:0042631 | BP | cellular response to water deprivation |
| 569 | plum2 | 60 | 4.0e-03 | 1.000 | 1 | GO:0046318 | BP | negative regulation of glucosylceramide biosynthetic process |
| 570 | plum2 | 60 | 4.0e-03 | 1.000 | 1 | GO:0072286 | BP | metanephric connecting tubule development |
| 571 | plum3 | 32 | 1.0e-03 | 1.000 | 2 | GO:0030947 | BP | regulation of vascular endothelial growth factor receptor signaling pathway |
| 572 | plum3 | 32 | 1.7e-03 | 1.000 | 2 | GO:0008210 | BP | estrogen metabolic process |
| 573 | plum3 | 32 | 2.1e-03 | 1.000 | 1 | GO:0010768 | BP | negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage |
| 574 | plum3 | 32 | 2.1e-03 | 1.000 | 1 | GO:0043041 | BP | amino acid activation for nonribosomal peptide biosynthetic process |
| 575 | plum3 | 32 | 2.1e-03 | 1.000 | 1 | GO:0034676 | CC | integrin alpha6-beta4 complex |
| 576 | plum3 | 32 | 2.1e-03 | 1.000 | 1 | GO:0008398 | MF | sterol 14-demethylase activity |
| 577 | plum3 | 32 | 4.1e-03 | 1.000 | 1 | GO:0010767 | BP | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage |
| 578 | plum3 | 32 | 4.1e-03 | 1.000 | 1 | GO:0044111 | BP | development involved in symbiotic interaction |
| 579 | plum3 | 32 | 4.1e-03 | 1.000 | 1 | GO:0071586 | BP | CAAX-box protein processing |
| 580 | plum3 | 32 | 4.1e-03 | 1.000 | 1 | GO:2000768 | BP | positive regulation of nephron tubule epithelial cell differentiation |
| 581 | purple | 202 | 1.8e-04 | 1.000 | 2 | GO:0071148 | CC | TEAD-1-YAP complex |
| 582 | purple | 202 | 5.3e-04 | 1.000 | 2 | GO:0004035 | MF | alkaline phosphatase activity |
| 583 | purple | 202 | 1.1e-03 | 1.000 | 2 | GO:0035481 | BP | positive regulation of Notch signaling pathway involved in heart induction |
| 584 | purple | 202 | 1.1e-03 | 1.000 | 2 | GO:0031682 | MF | G-protein gamma-subunit binding |
| 585 | purple | 202 | 1.4e-03 | 1.000 | 5 | GO:0000792 | CC | heterochromatin |
| 586 | purple | 202 | 1.7e-03 | 1.000 | 2 | GO:1903232 | BP | melanosome assembly |
| 587 | purple | 202 | 2.0e-03 | 1.000 | 3 | GO:0005721 | CC | pericentric heterochromatin |
| 588 | purple | 202 | 2.7e-03 | 1.000 | 3 | GO:0051123 | BP | RNA polymerase II preinitiation complex assembly |
| 589 | purple | 202 | 3.0e-03 | 1.000 | 27 | GO:0000785 | CC | chromatin |
| 590 | purple | 202 | 3.0e-03 | 1.000 | 3 | GO:0017025 | MF | TBP-class protein binding |
| 591 | red | 366 | 5.9e-04 | 1.000 | 2 | GO:0009826 | BP | unidimensional cell growth |
| 592 | red | 366 | 5.9e-04 | 1.000 | 2 | GO:1900924 | BP | negative regulation of glycine import across plasma membrane |
| 593 | red | 366 | 1.5e-03 | 1.000 | 3 | GO:0051956 | BP | negative regulation of amino acid transport |
| 594 | red | 366 | 1.7e-03 | 1.000 | 2 | GO:1903292 | BP | protein localization to Golgi membrane |
| 595 | red | 366 | 1.7e-03 | 1.000 | 2 | GO:0008048 | MF | calcium sensitive guanylate cyclase activator activity |
| 596 | red | 366 | 2.7e-03 | 1.000 | 3 | GO:0042487 | BP | regulation of odontogenesis of dentin-containing tooth |
| 597 | red | 366 | 3.4e-03 | 1.000 | 2 | GO:0061624 | BP | fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate |
| 598 | red | 366 | 3.4e-03 | 1.000 | 2 | GO:1903804 | BP | glycine import across plasma membrane |
| 599 | red | 366 | 3.4e-03 | 1.000 | 2 | GO:1990745 | CC | EARP complex |
| 600 | red | 366 | 3.4e-03 | 1.000 | 2 | GO:0030250 | MF | guanylate cyclase activator activity |
| 601 | royalblue | 140 | 5.0e-04 | 1.000 | 2 | GO:0070070 | BP | proton-transporting V-type ATPase complex assembly |
| 602 | royalblue | 140 | 5.0e-04 | 1.000 | 2 | GO:0070072 | BP | vacuolar proton-transporting V-type ATPase complex assembly |
| 603 | royalblue | 140 | 8.3e-04 | 1.000 | 2 | GO:0010694 | BP | positive regulation of alkaline phosphatase activity |
| 604 | royalblue | 140 | 1.7e-03 | 1.000 | 2 | GO:0070900 | BP | mitochondrial tRNA modification |
| 605 | royalblue | 140 | 2.9e-03 | 1.000 | 2 | GO:0002024 | BP | diet induced thermogenesis |
| 606 | royalblue | 140 | 3.1e-03 | 1.000 | 5 | GO:0045727 | BP | positive regulation of translation |
| 607 | royalblue | 140 | 3.1e-03 | 1.000 | 3 | GO:0010659 | BP | cardiac muscle cell apoptotic process |
| 608 | royalblue | 140 | 4.0e-03 | 1.000 | 3 | GO:0000959 | BP | mitochondrial RNA metabolic process |
| 609 | royalblue | 140 | 4.1e-03 | 1.000 | 4 | GO:0001540 | MF | amyloid-beta binding |
| 610 | royalblue | 140 | 4.4e-03 | 1.000 | 2 | GO:0090646 | BP | mitochondrial tRNA processing |
| 611 | saddlebrown | 100 | 3.7e-05 | 0.670 | 9 | GO:0007606 | BP | sensory perception of chemical stimulus |
| 612 | saddlebrown | 100 | 3.1e-04 | 1.000 | 4 | GO:0050909 | BP | sensory perception of taste |
| 613 | saddlebrown | 100 | 4.5e-04 | 1.000 | 7 | GO:0050907 | BP | detection of chemical stimulus involved in sensory perception |
| 614 | saddlebrown | 100 | 5.1e-04 | 1.000 | 4 | GO:0060170 | CC | ciliary membrane |
| 615 | saddlebrown | 100 | 6.2e-04 | 1.000 | 2 | GO:0050916 | BP | sensory perception of sweet taste |
| 616 | saddlebrown | 100 | 6.2e-04 | 1.000 | 2 | GO:0050917 | BP | sensory perception of umami taste |
| 617 | saddlebrown | 100 | 7.9e-04 | 1.000 | 4 | GO:0004722 | MF | protein serine/threonine phosphatase activity |
| 618 | saddlebrown | 100 | 9.4e-04 | 1.000 | 7 | GO:0009593 | BP | detection of chemical stimulus |
| 619 | saddlebrown | 100 | 9.5e-04 | 1.000 | 3 | GO:0050912 | BP | detection of chemical stimulus involved in sensory perception of taste |
| 620 | saddlebrown | 100 | 1.0e-03 | 1.000 | 5 | GO:0007224 | BP | smoothened signaling pathway |
| 621 | salmon | 175 | 2.8e-04 | 1.000 | 4 | GO:0017004 | BP | cytochrome complex assembly |
| 622 | salmon | 175 | 3.3e-04 | 1.000 | 6 | GO:0033108 | BP | mitochondrial respiratory chain complex assembly |
| 623 | salmon | 175 | 4.9e-04 | 1.000 | 3 | GO:0070131 | BP | positive regulation of mitochondrial translation |
| 624 | salmon | 175 | 9.0e-04 | 1.000 | 3 | GO:0033617 | BP | mitochondrial cytochrome c oxidase assembly |
| 625 | salmon | 175 | 1.3e-03 | 1.000 | 3 | GO:0008535 | BP | respiratory chain complex IV assembly |
| 626 | salmon | 175 | 1.3e-03 | 1.000 | 3 | GO:0005849 | CC | mRNA cleavage factor complex |
| 627 | salmon | 175 | 1.7e-03 | 1.000 | 3 | GO:0070129 | BP | regulation of mitochondrial translation |
| 628 | salmon | 175 | 1.7e-03 | 1.000 | 12 | GO:0042110 | BP | T cell activation |
| 629 | salmon | 175 | 2.7e-03 | 1.000 | 2 | GO:0048630 | BP | skeletal muscle tissue growth |
| 630 | salmon | 175 | 2.7e-03 | 1.000 | 2 | GO:0086016 | BP | AV node cell action potential |
| 631 | salmon2 | 28 | 1.9e-03 | 1.000 | 1 | GO:0019290 | BP | siderophore biosynthetic process |
| 632 | salmon2 | 28 | 1.9e-03 | 1.000 | 1 | GO:0070684 | BP | seminal clot liquefaction |
| 633 | salmon2 | 28 | 1.9e-03 | 1.000 | 1 | GO:0004751 | MF | ribose-5-phosphate isomerase activity |
| 634 | salmon2 | 28 | 1.9e-03 | 1.000 | 1 | GO:0047992 | MF | hydroxylysine kinase activity |
| 635 | salmon2 | 28 | 3.9e-03 | 1.000 | 1 | GO:0100026 | BP | positive regulation of DNA repair by transcription from RNA polymerase II promoter |
| 636 | salmon2 | 28 | 3.9e-03 | 1.000 | 1 | GO:0003858 | MF | 3-hydroxybutyrate dehydrogenase activity |
| 637 | salmon2 | 28 | 3.9e-03 | 1.000 | 1 | GO:0019202 | MF | amino acid kinase activity |
| 638 | salmon2 | 28 | 5.8e-03 | 1.000 | 1 | GO:0006014 | BP | D-ribose metabolic process |
| 639 | salmon2 | 28 | 5.8e-03 | 1.000 | 1 | GO:0032299 | CC | ribonuclease H2 complex |
| 640 | salmon2 | 28 | 5.8e-03 | 1.000 | 1 | GO:0038039 | CC | G protein-coupled receptor heterodimeric complex |
| 641 | salmon4 | 53 | 1.7e-04 | 1.000 | 2 | GO:2000253 | BP | positive regulation of feeding behavior |
| 642 | salmon4 | 53 | 3.2e-04 | 1.000 | 2 | GO:0044351 | BP | macropinocytosis |
| 643 | salmon4 | 53 | 1.5e-03 | 1.000 | 2 | GO:0034143 | BP | regulation of toll-like receptor 4 signaling pathway |
| 644 | salmon4 | 53 | 1.5e-03 | 1.000 | 2 | GO:0060259 | BP | regulation of feeding behavior |
| 645 | salmon4 | 53 | 1.6e-03 | 1.000 | 6 | GO:0051051 | BP | negative regulation of transport |
| 646 | salmon4 | 53 | 1.7e-03 | 1.000 | 2 | GO:0048520 | BP | positive regulation of behavior |
| 647 | salmon4 | 53 | 1.7e-03 | 1.000 | 2 | GO:0051537 | MF | 2 iron, 2 sulfur cluster binding |
| 648 | salmon4 | 53 | 2.0e-03 | 1.000 | 3 | GO:0002431 | BP | Fc receptor mediated stimulatory signaling pathway |
| 649 | salmon4 | 53 | 2.1e-03 | 1.000 | 2 | GO:0006907 | BP | pinocytosis |
| 650 | salmon4 | 53 | 2.6e-03 | 1.000 | 2 | GO:0051959 | MF | dynein light intermediate chain binding |
| 651 | sienna3 | 85 | 9.1e-05 | 1.000 | 2 | GO:0014054 | BP | positive regulation of gamma-aminobutyric acid secretion |
| 652 | sienna3 | 85 | 3.0e-04 | 1.000 | 2 | GO:0014052 | BP | regulation of gamma-aminobutyric acid secretion |
| 653 | sienna3 | 85 | 6.2e-04 | 1.000 | 2 | GO:0014051 | BP | gamma-aminobutyric acid secretion |
| 654 | sienna3 | 85 | 1.3e-03 | 1.000 | 2 | GO:0033182 | BP | regulation of histone ubiquitination |
| 655 | sienna3 | 85 | 1.6e-03 | 1.000 | 2 | GO:0015812 | BP | gamma-aminobutyric acid transport |
| 656 | sienna3 | 85 | 1.7e-03 | 1.000 | 11 | GO:0045087 | BP | innate immune response |
| 657 | sienna3 | 85 | 1.9e-03 | 1.000 | 2 | GO:0051957 | BP | positive regulation of amino acid transport |
| 658 | sienna3 | 85 | 2.3e-03 | 1.000 | 2 | GO:0042659 | BP | regulation of cell fate specification |
| 659 | sienna3 | 85 | 2.4e-03 | 1.000 | 6 | GO:0045088 | BP | regulation of innate immune response |
| 660 | sienna3 | 85 | 2.6e-03 | 1.000 | 2 | GO:0042423 | BP | catecholamine biosynthetic process |
| 661 | skyblue | 103 | 4.7e-04 | 1.000 | 2 | GO:0034715 | CC | pICln-Sm protein complex |
| 662 | skyblue | 103 | 1.7e-03 | 1.000 | 2 | GO:1900029 | BP | positive regulation of ruffle assembly |
| 663 | skyblue | 103 | 1.7e-03 | 1.000 | 6 | GO:0048705 | BP | skeletal system morphogenesis |
| 664 | skyblue | 103 | 2.1e-03 | 1.000 | 2 | GO:0005687 | CC | U4 snRNP |
| 665 | skyblue | 103 | 2.1e-03 | 1.000 | 2 | GO:0003746 | MF | translation elongation factor activity |
| 666 | skyblue | 103 | 2.2e-03 | 1.000 | 4 | GO:0071013 | CC | catalytic step 2 spliceosome |
| 667 | skyblue | 103 | 2.5e-03 | 1.000 | 2 | GO:0034709 | CC | methylosome |
| 668 | skyblue | 103 | 2.5e-03 | 1.000 | 2 | GO:0044292 | CC | dendrite terminus |
| 669 | skyblue | 103 | 3.6e-03 | 1.000 | 14 | GO:0048646 | BP | anatomical structure formation involved in morphogenesis |
| 670 | skyblue | 103 | 4.2e-03 | 1.000 | 3 | GO:0050840 | MF | extracellular matrix binding |
| 671 | skyblue1 | 36 | 2.4e-03 | 1.000 | 1 | GO:0032461 | BP | positive regulation of protein oligomerization |
| 672 | skyblue1 | 36 | 2.4e-03 | 1.000 | 1 | GO:1901398 | BP | regulation of transforming growth factor beta3 activation |
| 673 | skyblue1 | 36 | 2.4e-03 | 1.000 | 1 | GO:1903452 | BP | positive regulation of G1 to G0 transition |
| 674 | skyblue1 | 36 | 2.4e-03 | 1.000 | 1 | GO:1904899 | BP | positive regulation of hepatic stellate cell proliferation |
| 675 | skyblue1 | 36 | 2.4e-03 | 1.000 | 1 | GO:1990654 | BP | sebum secreting cell proliferation |
| 676 | skyblue1 | 36 | 2.4e-03 | 1.000 | 1 | GO:0032440 | MF | 2-alkenal reductase [NAD(P)+] activity |
| 677 | skyblue1 | 36 | 2.4e-03 | 1.000 | 1 | GO:0050353 | MF | trimethyllysine dioxygenase activity |
| 678 | skyblue1 | 36 | 2.4e-03 | 1.000 | 1 | GO:0051736 | MF | ATP-dependent polyribonucleotide 5’-hydroxyl-kinase activity |
| 679 | skyblue1 | 36 | 2.4e-03 | 1.000 | 1 | GO:0071567 | MF | UFM1 hydrolase activity |
| 680 | skyblue1 | 36 | 2.7e-03 | 1.000 | 2 | GO:1901998 | BP | toxin transport |
| 681 | skyblue2 | 39 | 1.8e-03 | 1.000 | 3 | GO:0098781 | BP | ncRNA transcription |
| 682 | skyblue2 | 39 | 2.6e-03 | 1.000 | 1 | GO:0007174 | BP | epidermal growth factor catabolic process |
| 683 | skyblue2 | 39 | 2.6e-03 | 1.000 | 1 | GO:0007495 | BP | visceral mesoderm-endoderm interaction involved in midgut development |
| 684 | skyblue2 | 39 | 2.6e-03 | 1.000 | 1 | GO:0018964 | BP | propylene metabolic process |
| 685 | skyblue2 | 39 | 2.6e-03 | 1.000 | 1 | GO:1990438 | BP | U6 2’-O-snRNA methylation |
| 686 | skyblue2 | 39 | 2.6e-03 | 1.000 | 1 | GO:0070685 | CC | macropinocytic cup |
| 687 | skyblue2 | 39 | 2.6e-03 | 1.000 | 1 | GO:0046525 | MF | xylosylprotein 4-beta-galactosyltransferase activity |
| 688 | skyblue2 | 39 | 2.6e-03 | 1.000 | 1 | GO:0051433 | MF | BH2 domain binding |
| 689 | skyblue2 | 39 | 2.7e-03 | 1.000 | 2 | GO:0045920 | BP | negative regulation of exocytosis |
| 690 | skyblue2 | 39 | 3.8e-03 | 1.000 | 2 | GO:0060999 | BP | positive regulation of dendritic spine development |
| 691 | skyblue3 | 81 | 4.4e-04 | 1.000 | 3 | GO:0008207 | BP | C21-steroid hormone metabolic process |
| 692 | skyblue3 | 81 | 6.4e-04 | 1.000 | 2 | GO:0001553 | BP | luteinization |
| 693 | skyblue3 | 81 | 6.4e-04 | 1.000 | 2 | GO:0009157 | BP | deoxyribonucleoside monophosphate biosynthetic process |
| 694 | skyblue3 | 81 | 1.5e-03 | 1.000 | 2 | GO:0042448 | BP | progesterone metabolic process |
| 695 | skyblue3 | 81 | 1.5e-03 | 1.000 | 2 | GO:0061029 | BP | eyelid development in camera-type eye |
| 696 | skyblue3 | 81 | 2.0e-03 | 1.000 | 2 | GO:0090083 | BP | regulation of inclusion body assembly |
| 697 | skyblue3 | 81 | 2.3e-03 | 1.000 | 2 | GO:0009263 | BP | deoxyribonucleotide biosynthetic process |
| 698 | skyblue3 | 81 | 2.7e-03 | 1.000 | 2 | GO:0010744 | BP | positive regulation of macrophage derived foam cell differentiation |
| 699 | skyblue3 | 81 | 3.0e-03 | 1.000 | 2 | GO:0009200 | BP | deoxyribonucleoside triphosphate metabolic process |
| 700 | skyblue3 | 81 | 3.4e-03 | 1.000 | 2 | GO:0061608 | MF | nuclear import signal receptor activity |
| 701 | steelblue | 101 | 1.5e-03 | 1.000 | 4 | GO:0032588 | CC | trans-Golgi network membrane |
| 702 | steelblue | 101 | 2.3e-03 | 1.000 | 2 | GO:0045199 | BP | maintenance of epithelial cell apical/basal polarity |
| 703 | steelblue | 101 | 2.8e-03 | 1.000 | 2 | GO:0021930 | BP | cerebellar granule cell precursor proliferation |
| 704 | steelblue | 101 | 3.2e-03 | 1.000 | 2 | GO:0021534 | BP | cell proliferation in hindbrain |
| 705 | steelblue | 101 | 3.2e-03 | 1.000 | 2 | GO:0016805 | MF | dipeptidase activity |
| 706 | steelblue | 101 | 3.8e-03 | 1.000 | 2 | GO:0045779 | BP | negative regulation of bone resorption |
| 707 | steelblue | 101 | 4.2e-03 | 1.000 | 3 | GO:0061951 | BP | establishment of protein localization to plasma membrane |
| 708 | steelblue | 101 | 4.9e-03 | 1.000 | 2 | GO:0030011 | BP | maintenance of cell polarity |
| 709 | steelblue | 101 | 4.9e-03 | 1.000 | 2 | GO:0046851 | BP | negative regulation of bone remodeling |
| 710 | steelblue | 101 | 5.6e-03 | 1.000 | 2 | GO:0035493 | BP | SNARE complex assembly |
| 711 | tan | 185 | 5.2e-05 | 0.960 | 4 | GO:0048025 | BP | negative regulation of mRNA splicing, via spliceosome |
| 712 | tan | 185 | 8.1e-05 | 1.000 | 4 | GO:0033119 | BP | negative regulation of RNA splicing |
| 713 | tan | 185 | 8.3e-04 | 1.000 | 2 | GO:0070602 | BP | regulation of centromeric sister chromatid cohesion |
| 714 | tan | 185 | 1.4e-03 | 1.000 | 2 | GO:1903955 | BP | positive regulation of protein targeting to mitochondrion |
| 715 | tan | 185 | 2.6e-03 | 1.000 | 15 | GO:0071363 | BP | cellular response to growth factor stimulus |
| 716 | tan | 185 | 2.8e-03 | 1.000 | 3 | GO:0008209 | BP | androgen metabolic process |
| 717 | tan | 185 | 3.1e-03 | 1.000 | 8 | GO:0071560 | BP | cellular response to transforming growth factor beta stimulus |
| 718 | tan | 185 | 3.7e-03 | 1.000 | 8 | GO:0071559 | BP | response to transforming growth factor beta |
| 719 | tan | 185 | 3.8e-03 | 1.000 | 2 | GO:0046886 | BP | positive regulation of hormone biosynthetic process |
| 720 | tan | 185 | 4.0e-03 | 1.000 | 15 | GO:0070848 | BP | response to growth factor |
| 721 | thistle | 28 | 3.6e-03 | 1.000 | 3 | GO:0005516 | MF | calmodulin binding |
| 722 | thistle | 28 | 3.7e-03 | 1.000 | 1 | GO:0036316 | BP | SREBP-SCAP complex retention in endoplasmic reticulum |
| 723 | thistle | 28 | 3.7e-03 | 1.000 | 1 | GO:2000349 | BP | negative regulation of CD40 signaling pathway |
| 724 | thistle | 28 | 3.7e-03 | 1.000 | 1 | GO:0000438 | CC | core TFIIH complex portion of holo TFIIH complex |
| 725 | thistle | 28 | 3.7e-03 | 1.000 | 1 | GO:0031251 | CC | PAN complex |
| 726 | thistle | 28 | 5.6e-03 | 1.000 | 1 | GO:0002277 | BP | myeloid dendritic cell activation involved in immune response |
| 727 | thistle | 28 | 5.6e-03 | 1.000 | 1 | GO:0044830 | BP | modulation by host of viral RNA genome replication |
| 728 | thistle | 28 | 5.6e-03 | 1.000 | 1 | GO:2000639 | BP | negative regulation of SREBP signaling pathway |
| 729 | thistle | 28 | 5.6e-03 | 1.000 | 1 | GO:0032937 | CC | SREBP-SCAP-Insig complex |
| 730 | thistle | 28 | 5.6e-03 | 1.000 | 1 | GO:1902937 | CC | inward rectifier potassium channel complex |
| 731 | thistle1 | 57 | 2.1e-04 | 1.000 | 2 | GO:1900223 | BP | positive regulation of amyloid-beta clearance |
| 732 | thistle1 | 57 | 4.2e-04 | 1.000 | 5 | GO:0030100 | BP | regulation of endocytosis |
| 733 | thistle1 | 57 | 9.2e-04 | 1.000 | 2 | GO:1902430 | BP | negative regulation of amyloid-beta formation |
| 734 | thistle1 | 57 | 1.3e-03 | 1.000 | 2 | GO:1900221 | BP | regulation of amyloid-beta clearance |
| 735 | thistle1 | 57 | 1.3e-03 | 1.000 | 2 | GO:1902992 | BP | negative regulation of amyloid precursor protein catabolic process |
| 736 | thistle1 | 57 | 1.3e-03 | 1.000 | 2 | GO:1903830 | BP | magnesium ion transmembrane transport |
| 737 | thistle1 | 57 | 1.3e-03 | 1.000 | 2 | GO:0015095 | MF | magnesium ion transmembrane transporter activity |
| 738 | thistle1 | 57 | 1.4e-03 | 1.000 | 2 | GO:0015693 | BP | magnesium ion transport |
| 739 | thistle1 | 57 | 1.6e-03 | 1.000 | 7 | GO:0006897 | BP | endocytosis |
| 740 | thistle1 | 57 | 1.9e-03 | 1.000 | 2 | GO:0035020 | BP | regulation of Rac protein signal transduction |
| 741 | thistle2 | 57 | 2.6e-04 | 1.000 | 2 | GO:0030991 | CC | intraciliary transport particle A |
| 742 | thistle2 | 57 | 3.4e-04 | 1.000 | 3 | GO:0035735 | BP | intraciliary transport involved in cilium assembly |
| 743 | thistle2 | 57 | 3.6e-04 | 1.000 | 4 | GO:0008630 | BP | intrinsic apoptotic signaling pathway in response to DNA damage |
| 744 | thistle2 | 57 | 4.3e-04 | 1.000 | 3 | GO:0097542 | CC | ciliary tip |
| 745 | thistle2 | 57 | 4.5e-04 | 1.000 | 2 | GO:0035721 | BP | intraciliary retrograde transport |
| 746 | thistle2 | 57 | 5.7e-04 | 1.000 | 4 | GO:0097731 | CC | 9+0 non-motile cilium |
| 747 | thistle2 | 57 | 6.0e-04 | 1.000 | 3 | GO:0042073 | BP | intraciliary transport |
| 748 | thistle2 | 57 | 7.7e-04 | 1.000 | 9 | GO:0070925 | BP | organelle assembly |
| 749 | thistle2 | 57 | 1.1e-03 | 1.000 | 4 | GO:0097730 | CC | non-motile cilium |
| 750 | thistle2 | 57 | 1.2e-03 | 1.000 | 3 | GO:0098840 | BP | protein transport along microtubule |
| 751 | thistle3 | 30 | 1.7e-03 | 1.000 | 3 | GO:0019903 | MF | protein phosphatase binding |
| 752 | thistle3 | 30 | 2.0e-03 | 1.000 | 1 | GO:0018276 | BP | isopeptide cross-linking via N6-glycyl-L-lysine |
| 753 | thistle3 | 30 | 2.0e-03 | 1.000 | 1 | GO:0034247 | BP | snoRNA splicing |
| 754 | thistle3 | 30 | 2.0e-03 | 1.000 | 1 | GO:0036325 | BP | vascular endothelial growth factor receptor-3 signaling pathway |
| 755 | thistle3 | 30 | 2.0e-03 | 1.000 | 1 | GO:0038115 | BP | chemokine (C-C motif) ligand 19 signaling pathway |
| 756 | thistle3 | 30 | 2.0e-03 | 1.000 | 1 | GO:2000522 | BP | positive regulation of immunological synapse formation |
| 757 | thistle3 | 30 | 2.0e-03 | 1.000 | 1 | GO:2000526 | BP | positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation |
| 758 | thistle3 | 30 | 2.0e-03 | 1.000 | 1 | GO:0005119 | MF | smoothened binding |
| 759 | thistle3 | 30 | 2.0e-03 | 1.000 | 1 | GO:0035757 | MF | chemokine (C-C motif) ligand 19 binding |
| 760 | thistle3 | 30 | 2.0e-03 | 1.000 | 1 | GO:0035758 | MF | chemokine (C-C motif) ligand 21 binding |
| 761 | turquoise | 2875 | 6.7e-04 | 1.000 | 16 | GO:0006656 | BP | phosphatidylcholine biosynthetic process |
| 762 | turquoise | 2875 | 7.7e-04 | 1.000 | 44 | GO:0051427 | MF | hormone receptor binding |
| 763 | turquoise | 2875 | 9.2e-04 | 1.000 | 8 | GO:0006910 | BP | phagocytosis, recognition |
| 764 | turquoise | 2875 | 9.6e-04 | 1.000 | 6 | GO:1904338 | BP | regulation of dopaminergic neuron differentiation |
| 765 | turquoise | 2875 | 1.0e-03 | 1.000 | 12 | GO:0004181 | MF | metallocarboxypeptidase activity |
| 766 | turquoise | 2875 | 1.1e-03 | 1.000 | 95 | GO:0009314 | BP | response to radiation |
| 767 | turquoise | 2875 | 1.3e-03 | 1.000 | 5 | GO:0002118 | BP | aggressive behavior |
| 768 | turquoise | 2875 | 1.3e-03 | 1.000 | 5 | GO:0008290 | CC | F-actin capping protein complex |
| 769 | turquoise | 2875 | 2.5e-03 | 1.000 | 16 | GO:0000731 | BP | DNA synthesis involved in DNA repair |
| 770 | turquoise | 2875 | 2.5e-03 | 1.000 | 14 | GO:0019985 | BP | translesion synthesis |
| 771 | violet | 92 | 2.1e-04 | 1.000 | 2 | GO:0006273 | BP | lagging strand elongation |
| 772 | violet | 92 | 7.4e-04 | 1.000 | 2 | GO:0048102 | BP | autophagic cell death |
| 773 | violet | 92 | 7.4e-04 | 1.000 | 2 | GO:0030619 | MF | U1 snRNA binding |
| 774 | violet | 92 | 9.8e-04 | 1.000 | 2 | GO:0000796 | CC | condensin complex |
| 775 | violet | 92 | 1.9e-03 | 1.000 | 2 | GO:0051561 | BP | positive regulation of mitochondrial calcium ion concentration |
| 776 | violet | 92 | 3.6e-03 | 1.000 | 2 | GO:0070206 | BP | protein trimerization |
| 777 | violet | 92 | 4.5e-03 | 1.000 | 11 | GO:0046983 | MF | protein dimerization activity |
| 778 | violet | 92 | 5.7e-03 | 1.000 | 2 | GO:0006271 | BP | DNA strand elongation involved in DNA replication |
| 779 | violet | 92 | 6.0e-03 | 1.000 | 1 | GO:0010585 | BP | glutamine secretion |
| 780 | violet | 92 | 6.0e-03 | 1.000 | 1 | GO:0022615 | BP | protein to membrane docking |
| 781 | white | 102 | 9.2e-04 | 1.000 | 2 | GO:0005138 | MF | interleukin-6 receptor binding |
| 782 | white | 102 | 1.6e-03 | 1.000 | 2 | GO:0043995 | MF | histone acetyltransferase activity (H4-K5 specific) |
| 783 | white | 102 | 1.6e-03 | 1.000 | 2 | GO:0043996 | MF | histone acetyltransferase activity (H4-K8 specific) |
| 784 | white | 102 | 1.9e-03 | 1.000 | 2 | GO:0046972 | MF | histone acetyltransferase activity (H4-K16 specific) |
| 785 | white | 102 | 2.8e-03 | 1.000 | 2 | GO:0009313 | BP | oligosaccharide catabolic process |
| 786 | white | 102 | 5.0e-03 | 1.000 | 2 | GO:0043981 | BP | histone H4-K5 acetylation |
| 787 | white | 102 | 5.0e-03 | 1.000 | 2 | GO:0043982 | BP | histone H4-K8 acetylation |
| 788 | white | 102 | 5.0e-03 | 1.000 | 2 | GO:0010485 | MF | H4 histone acetyltransferase activity |
| 789 | white | 102 | 6.7e-03 | 1.000 | 1 | GO:0007225 | BP | patched ligand maturation |
| 790 | white | 102 | 6.7e-03 | 1.000 | 1 | GO:0009590 | BP | detection of gravity |
| 791 | yellow | 439 | 3.3e-04 | 1.000 | 11 | GO:0001650 | CC | fibrillar center |
| 792 | yellow | 439 | 7.3e-04 | 1.000 | 76 | GO:0016740 | MF | transferase activity |
| 793 | yellow | 439 | 7.6e-04 | 1.000 | 3 | GO:0006489 | BP | dolichyl diphosphate biosynthetic process |
| 794 | yellow | 439 | 7.6e-04 | 1.000 | 3 | GO:0014012 | BP | peripheral nervous system axon regeneration |
| 795 | yellow | 439 | 8.3e-04 | 1.000 | 2 | GO:0007181 | BP | transforming growth factor beta receptor complex assembly |
| 796 | yellow | 439 | 8.3e-04 | 1.000 | 2 | GO:0019408 | BP | dolichol biosynthetic process |
| 797 | yellow | 439 | 8.3e-04 | 1.000 | 2 | GO:0034673 | CC | inhibin-betaglycan-ActRII complex |
| 798 | yellow | 439 | 1.3e-03 | 1.000 | 22 | GO:0019787 | MF | ubiquitin-like protein transferase activity |
| 799 | yellow | 439 | 1.5e-03 | 1.000 | 13 | GO:0045216 | BP | cell-cell junction organization |
| 800 | yellow | 439 | 1.5e-03 | 1.000 | 56 | GO:0006952 | BP | defense response |
| 801 | yellow4 | 34 | 1.5e-04 | 1.000 | 2 | GO:2000344 | BP | positive regulation of acrosome reaction |
| 802 | yellow4 | 34 | 2.9e-04 | 1.000 | 2 | GO:0060046 | BP | regulation of acrosome reaction |
| 803 | yellow4 | 34 | 2.9e-04 | 1.000 | 2 | GO:1905516 | BP | positive regulation of fertilization |
| 804 | yellow4 | 34 | 3.5e-04 | 1.000 | 3 | GO:0009988 | BP | cell-cell recognition |
| 805 | yellow4 | 34 | 7.2e-04 | 1.000 | 2 | GO:0048305 | BP | immunoglobulin secretion |
| 806 | yellow4 | 34 | 1.1e-03 | 1.000 | 2 | GO:0080154 | BP | regulation of fertilization |
| 807 | yellow4 | 34 | 1.7e-03 | 1.000 | 2 | GO:0007340 | BP | acrosome reaction |
| 808 | yellow4 | 34 | 2.2e-03 | 1.000 | 3 | GO:0007338 | BP | single fertilization |
| 809 | yellow4 | 34 | 2.4e-03 | 1.000 | 1 | GO:0006437 | BP | tyrosyl-tRNA aminoacylation |
| 810 | yellow4 | 34 | 2.4e-03 | 1.000 | 1 | GO:0070184 | BP | mitochondrial tyrosyl-tRNA aminoacylation |
| 811 | yellowgreen | 78 | 7.4e-06 | 0.140 | 4 | GO:0051930 | BP | regulation of sensory perception of pain |
| 812 | yellowgreen | 78 | 5.2e-05 | 0.950 | 5 | GO:0019233 | BP | sensory perception of pain |
| 813 | yellowgreen | 78 | 2.7e-04 | 1.000 | 3 | GO:0033198 | BP | response to ATP |
| 814 | yellowgreen | 78 | 3.3e-04 | 1.000 | 10 | GO:0043065 | BP | positive regulation of apoptotic process |
| 815 | yellowgreen | 78 | 3.6e-04 | 1.000 | 10 | GO:0043068 | BP | positive regulation of programmed cell death |
| 816 | yellowgreen | 78 | 6.8e-04 | 1.000 | 10 | GO:0010942 | BP | positive regulation of cell death |
| 817 | yellowgreen | 78 | 9.1e-04 | 1.000 | 2 | GO:0030877 | CC | beta-catenin destruction complex |
| 818 | yellowgreen | 78 | 1.3e-03 | 1.000 | 3 | GO:0001102 | MF | RNA polymerase II activating transcription factor binding |
| 819 | yellowgreen | 78 | 1.4e-03 | 1.000 | 2 | GO:0008035 | MF | high-density lipoprotein particle binding |
| 820 | yellowgreen | 78 | 2.1e-03 | 1.000 | 3 | GO:0050909 | BP | sensory perception of taste |
Xarxa cytoscape
Factors de transcripció tots els mòduls associats
Factors de transcripció mòduls per separat
resultsSubset_darkgreen.csv
| X | logo | geneSet | motif | NES | AUC | TF_highConf | TF_lowConf | nEnrGenes | rankAtMax | enrichedGenes |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | geneSet | cisbp__M3913 | 4.48 | 0.0633 | SOX5 (directAnnotation). | 22 | 699 | C15orf54;CKAP5;DOCK4;DPYSL3;EPB41;ETV1;FGF9;HOPX;HOXC6;MDK;PCBP4;PHLDA3;PPP1R14C;RAPGEF2;RMND5A;RPS6KA5;SLC4A10;SOCS5;SYNE2;TMSB4X;VAMP1;XIAP | ||
| 2 | geneSet | transfac_public__M00042 | 4.27 | 0.0616 | SOX5 (directAnnotation). | 23 | 813 | C15orf54;CKAP5;DOCK4;DPYSL3;EPB41;ETV1;FGF9;HOPX;HOXC6;HTR2C;MDK;PCBP4;PHLDA3;PPP1R14C;RAPGEF2;RMND5A;RPS6KA5;SLC4A10;SOCS5;SYNE2;TMSB4X;VAMP1;XIAP | ||
| 3 | geneSet | elemento__GCTCCGC | 4.26 | 0.0615 | 15 | 392 | ARHGAP21;ETV1;FGF9;FGFRL1;HIVEP1;HOPX;HOXC6;HTR2C;KDELR1;LIPA;MAP1A;MTMR4;PCBP4;ZBTB10;ZHX2 | |||
| 4 | geneSet | flyfactorsurvey__Ct_Cell_FBgn0004198 | 4.11 | 0.0604 | CUX1; CUX2 (inferredBy_Orthology). | 27 | 1105 | CDH3;CKAP5;CLIC6;CUL2;DLX6;EPB41;FAM86B1;FGF9;GOLGA1;HIVEP1;HOPX;ILDR2;KLHL13;MMP9;PLEKHF2;PLSCR3;RWDD3;SLC4A10;SLC7A7;SNX10;SOCS5;ST3GAL2;TAB3;UHRF1BP1L;VAMP1;XIAP;ZHX2 | ||
| 5 | geneSet | stark__RBYGTGRGAAMCB | 3.94 | 0.0591 | RBPJ; RBPJL (inferredBy_Orthology). | 25 | 996 | ARFGEF2;CASK;CRBN;DOCK4;EPB41;FGFRL1;H2AFY;HOXC6;ILDR2;KIAA1804;KLHL13;LIPG;MCOLN3;OR4F6;PLCL1;PLEKHF2;PPP1R14C;RMND5A;SH2B2;SLC26A9;SLC38A5;SLC7A7;TBCC;TMOD1;TTYH3 | ||
| 6 | geneSet | transfac_pro__M08801 | 3.93 | 0.0590 | CEBPE (directAnnotation). | CEBPA; CEBPB (inferredBy_MotifSimilarity). | 27 | 1087 | ADAMTS16;C8orf37;CASK;CLDN18;CRBN;CUL2;DOCK4;DPYSL3;DSPP;ETV1;FGF9;HIVEP1;HMGN5;HOPX;HOXC6;HTR2C;KLHL13;KRT17;MMP9;NR1D2;PCDH12;PPP1R14C;RWDD3;SLC7A7;SPP1;STK38;VAMP1 | |
| 7 | geneSet | dbcorrdb__FOS__ENCSR000EYZ_1__m2 | 3.90 | 0.0587 | FOS (directAnnotation). | NFYA; NFYB; PBX3; SP1; SP2; SP3; SP4 (inferredBy_MotifSimilarity). | 23 | 896 | ALDH16A1;CALM3;ELL;ETV1;FAM86B1;GDF9;HIVEP1;HOXC6;LIN52;LIPA;MMP9;MORN4;MTMR4;NASP;PLEKHF2;RPS6KA5;SETD3;SOCS5;TMEM60;TP53;TTYH3;VPS26A;ZHX2 | |
| 8 | geneSet | taipale_cyt_meth__PRDM4_YRRCRGTTTCRAGGGTTACC_eDBD_meth | 3.71 | 0.0572 | PRDM4 (directAnnotation). | 82 | 4969 | ABCC9;ADAMTS16;ALDH16A1;ANKRD26;ANKRD30B;AP3B1;APIP;APOOL;ARFGEF2;ARHGAP21;ARHGEF40;ASB6;ATG16L1;BLNK;BTBD1;C15orf39;C15orf54;C1orf189;CALM3;CASK;CHMP4B;CT45A3;DERA;DLX6;DPYSL3;ELL;ENO1;ETV1;FAHD2A;FAM86B1;GOLIM4;GPR75;GRAMD2;H2AFY;HIVEP1;HMGN5;HOPX;HOXC6;HTR2C;ITCH;ITGB6;KCNK15;KIAA1804;KLHL13;LCK;LIPA;LMNB2;LTN1;MAGED1;MAP1A;MMGT1;MTMR4;NASP;NR1D2;OR4F6;PCBP4;PCDH12;PRKAR2A;RAB38;RAET1L;RMND5A;RNF126;SETD3;SLC17A9;SLC26A9;SMARCC2;SPP1;TAB3;TAS2R20;TBCC;TGFB3;THEMIS;TIGD4;TMSB4X;TRIML1;TUBB1;TYRO3;ULBP2;ZBTB38;ZHX2;ZNF727;ZNF98 | ||
| 9 | geneSet | transfac_pro__M09127 | 3.68 | 0.0569 | CEBPZ; CPEB1; IRF3; IRF4; MAFK; PRDM1; RAD21; SMARCA4; SPI1; SREBF2 (inferredBy_MotifSimilarity). | 17 | 472 | ARHGAP21;BRWD3;C15orf54;CHMP4B;HIPK3;PHLDA3;PLEKHF2;RWDD3;SLC26A9;SLC7A7;SNUPN;ST3GAL2;STK38;TAB3;TGFB3;VAMP1;ZHX2 | ||
| 10 | geneSet | taipale_tf_pairs__Hoxa10_TTCTGG40NTGC_HT_1 | 3.65 | 0.0568 | 16 | 533 | C8orf37;CDH3;DPYSL3;EPB41;EPRS;FGF9;GOLIM4;HIVEP1;HOXC6;HTR2C;KLHL13;PLEKHF2;PPP1R14C;SOCS5;TYRO3;XIAP |
resultsSubset_darkturquoise.csv
| X | logo | geneSet | motif | NES | AUC | TF_highConf | TF_lowConf | nEnrGenes | rankAtMax | enrichedGenes |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | geneSet | taipale__TBX1_DBD_AGGTGTGAAWTTCACACCT | 5.24 | 0.0817 | TBX1 (directAnnotation). | EOMES; T; TBR1; TBX15; TBX18; TBX19; TBX2; TBX20; TBX22; TBX3; TBX4 (inferredBy_MotifSimilarity). TBX6 (inferredBy_MotifSimilarity_n_Orthology). | 12 | 496 | CLIC6;ENO1;FAM86B1;GDF9;GLRA2;HSD3B1;MAGED1;PCDH12;RBM43;RPS6KA5;TMEM211;XKR9 | |
| 2 | geneSet | taipale_tf_pairs__ETV2_FOXO6_RCCGGATGTTKWN_CAP | 5.20 | 0.0812 | ETV2; FOXO6 (directAnnotation). | 21 | 1258 | AJAP1;ALDH16A1;C15orf54;DLX6;DOCK4;ENO1;MAGED1;MORN4;MTMR4;OSTN;PCDH12;PILRB;PLCL1;SCRN3;SLC4A10;ST3GAL2;TBCC;TIGD4;TMEM211;TP53;VAMP1 | ||
| 3 | geneSet | cisbp__M3628 | 4.93 | 0.0783 | NFYA (directAnnotation). | FOXI1; IRF3; NFYB; NFYC (inferredBy_MotifSimilarity). PBX1 (inferredBy_MotifSimilarity_n_Orthology). | 16 | 917 | C1orf189;CDH3;COL1A2;DSPP;H2AFY;HTR2C;LIN52;LIPA;LIPG;MORN4;RPS6KA5;SOCS5;WASH1;ZBTB10;ZC3H14;ZNF555 | |
| 4 | geneSet | taipale__TBX15_DBD_AGGTGTGAANTTCACACCT_repr | 4.86 | 0.0776 | TBX15 (directAnnotation). | EOMES; MGA; T; TBR1; TBX1; TBX18; TBX19; TBX2; TBX20; TBX22; TBX3; TBX4; TBX5 (inferredBy_MotifSimilarity). TBX10; TBX21; TBX6 (inferredBy_MotifSimilarity_n_Orthology). | 13 | 775 | COL1A2;ENO1;GDF9;GLRA2;HSD3B1;MAGED1;MCOLN3;NASP;RBM43;RPS6KA5;TMEM211;WSCD1;XKR9 | |
| 5 | geneSet | taipale_cyt_meth__TLX3_NAATTGNNNNNNNNNNNNNCAATTN_eDBD_repr | 4.76 | 0.0764 | TLX3 (directAnnotation). | 9 | 199 | ANKRD30B;BLNK;CKAP5;DPYSL3;HTR2C;PLCL1;TBCC;THEMIS;TMEM60 | ||
| 6 | geneSet | dbcorrdb__FOS__ENCSR000EYZ_1__m2 | 4.54 | 0.0741 | FOS (directAnnotation). | NFYA; NFYB; PBX3; SP1; SP2; SP3; SP4 (inferredBy_MotifSimilarity). | 16 | 1143 | ALDH16A1;FAM86B1;GDF9;LIN52;LIPA;MORN4;MTMR4;NASP;PLEKHF2;RPS6KA5;SOCS5;SPEF1;TMEM60;TP53;TTYH3;VAMP1 | |
| 7 | geneSet | predrem__nrMotif1472 | 4.49 | 0.0735 | 9 | 304 | ANKRD30B;CDH3;COL1A2;HTR2C;MAP1A;RAB38;TBCC;TIGD4;VAMP1 | |||
| 8 | geneSet | taipale_cyt_meth__SOX18_NACAATGN_eDBD_repr | 4.26 | 0.0710 | SOX18 (directAnnotation). | 11 | 473 | DOCK4;GLRA2;H2AFY;HOPX;KLHL13;PLCL1;SLC14A2;THEMIS;TTC30A;VAMP1;ZBTB10 | ||
| 9 | geneSet | hocomoco__ZN586_HUMAN.H11MO.0.C | 4.17 | 0.0700 | ZNF586 (directAnnotation). | 11 | 500 | AP3B1;H2AFY;LIPA;MAGED1;MCOLN3;OSTN;RAB38;SLC14A2;VAMP1;WASH1;ZNF546 | ||
| 10 | geneSet | cisbp__M3913 | 4.10 | 0.0693 | SOX5 (directAnnotation). | 12 | 776 | C15orf54;CKAP5;DOCK4;DPYSL3;FGF9;HOPX;HTR2C;PHLDA3;RPS6KA5;SLC4A10;SOCS5;VAMP1 |
NA
| X | logo | geneSet | motif | NES | AUC | TF_highConf | TF_lowConf | nEnrGenes | rankAtMax | enrichedGenes |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | geneSet | hocomoco__RXRG_MOUSE.H11MO.0.B | 4.42 | 0.0832 | RXRG (inferredBy_Orthology). | ESRRG; NR2F1; NR5A1; NR5A2; NR6A1; RARA (inferredBy_MotifSimilarity). ESRRA; ESRRB; RARG; RXRA (inferredBy_MotifSimilarity_n_Orthology). | 17 | 900 | ARHGAP21;BTBD1;CUL2;ELL;EPB41;HIPK3;ITCH;MMP12;MMP9;PRKAR2A;RIMS2;SH2B2;SLC7A7;SNX10;STK38;TGFB3;ZHX2 | |
| 2 | geneSet | neph__UW.Motif.0288 | 4.10 | 0.0795 | 14 | 694 | ARHGAP21;EPB41;MMP9;PPP1R14C;PRKAR2A;RAPGEF2;RIMS2;SCYL2;SLC17A9;SLC7A7;SYNJ2;TGFB3;TPSD1;ZHX2 | |||
| 3 | geneSet | dbcorrdb__EGR1__ENCSR000BJA_1__m1 | 4.08 | 0.0793 | EGR1 (directAnnotation). | BRF1; BRF2; CEBPB; CTCF; CUX1; E2F6; EGR2; EGR3; EGR4; ELK4; ESRRA; EZH2; FOS; GABPA; HDAC2; IRF1; KLF1; KLF15; KLF16; KLF3; KLF5; KLF6; MAX; MAZ; MXI1; NELFE; PATZ1; PAX5; PBX3; POLR2A; RAD21; RBBP5; RCOR1; REST; SMARCA4; SP1; SP2; SP3; SP4; SREBF1; SREBF2; SUPT20H; TBX15; TEAD2; VEZF1; WT1; XRCC4; ZBTB7B; ZMIZ1; ZNF274; ZNF467 (inferredBy_MotifSimilarity). SP5; ZBTB17; ZNF16; ZNF189; ZNF23; ZNF429; ZNF471; ZNF502; ZNF607; ZNF84 (inferredBy_MotifSimilarity_n_Orthology). | 17 | 941 | CASK;EPB41;ETV1;FRS2;HIVEP1;HOXC6;ILDR2;MMP9;PCBP4;PLSCR3;SETD3;SH2B2;SLC7A7;STK38;TAB3;TGFB3;ZHX2 | |
| 4 | geneSet | tiffin__TIFDMEM0000108 | 4.01 | 0.0784 | 18 | 1159 | ASB6;CASK;EPB41;FRS2;HOXC6;MMP12;NR1D2;PRKAR2A;RAPGEF2;RIMS2;RMND5A;SLC7A7;SNX10;SPP1;STK38;XIAP;ZC3H3;ZHX2 | |||
| 5 | geneSet | flyfactorsurvey__Ct_Cell_FBgn0004198 | 3.95 | 0.0778 | CUX1; CUX2 (inferredBy_Orthology). | 11 | 353 | GOLGA1;HIVEP1;ILDR2;MMP9;PLSCR3;RWDD3;SLC7A7;SNX10;TAB3;XIAP;ZHX2 | ||
| 6 | geneSet | elemento__GCAGCGC | 3.95 | 0.0778 | 14 | 676 | AIM1;C8orf37;CHRNA7;ETV1;FGFRL1;FRS2;HIPK3;HIVEP1;HOXC6;ILDR2;MMP9;RNF126;SLC7A7;ZHX2 | |||
| 7 | geneSet | transfac_pro__M05327 | 3.70 | 0.0748 | WT1 (directAnnotation). | 13 | 716 | ARHGAP21;CRISPLD2;EPB41;HIPK3;HIVEP1;ITCH;KDELR1;PCBP4;SH2B2;SYCP2;TPRG1;TPSD1;ZHX2 | ||
| 8 | geneSet | homer__GGGGGAATCCCC_NFkB-p50_p52 | 3.69 | 0.0747 | NFKB1 (directAnnotation). | NFKB2 (inferredBy_MotifSimilarity). REL; RELA; RELB (inferredBy_MotifSimilarity_n_Orthology). | 15 | 893 | ARFGEF2;ARHGEF40;C8orf37;CLDN18;EPB41;HIVEP1;HOXC6;IL23A;KDELR1;MMP9;PCBP4;PRDX5;SLC26A9;TAB3;ZHX2 | |
| 9 | geneSet | dbcorrdb__RAD21__ENCSR000EHX_1__m7 | 3.65 | 0.0742 | RAD21 (directAnnotation). | BRF1; BRF2; CEBPB; CREB1; CTCF; CUX1; E2F1; E2F6; EGR1; ELF1; ELK4; ESRRA; EZH2; GABPA; HCFC1; HDAC2; HIC1; IRF1; JUND; KAT2A; KLF16; KLF3; MAX; MAZ; MXI1; MYC; NELFE; NFYB; PBX3; POLR2A; POLR3G; RBBP5; RCOR1; REST; SMARCA4; SP1; SP2; SP3; SP4; SREBF1; SREBF2; SUPT20H; TBX15; WRNIP1; WT1; XRCC4; ZBTB7A; ZBTB7B; ZC3H11A; ZFX; ZMIZ1; ZNF263; ZNF274 (inferredBy_MotifSimilarity). ZFY (inferredBy_MotifSimilarity_n_Orthology). | 15 | 845 | ARHGAP21;EPB41;FRS2;HIPK3;HIVEP1;HOXC6;ILDR2;RIMS2;SH2B2;SLC38A5;STK38;SYNE2;TAB3;TYRO3;ZHX2 | |
| 10 | geneSet | transfac_pro__M09127 | 3.64 | 0.0741 | CEBPZ; CPEB1; IRF3; IRF4; MAFK; PRDM1; RAD21; SMARCA4; SPI1; SREBF2 (inferredBy_MotifSimilarity). | 13 | 564 | ARHGAP21;BRWD3;CHMP4B;GOLGA1;HIPK3;RWDD3;SLC26A9;SLC7A7;SNUPN;STK38;TAB3;TGFB3;ZHX2 |